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Background: Contraception is widely used by women to prevent pregnancy and for other 
health-related reasons. In Canada, many contraceptive users may be living in larger bodies. 
While there is a growing interest in the reproductive health care experiences of women in larger 
bodies, less attention has been paid to contraception. Research suggests that women in larger 
bodies may receive inadequate contraceptive counselling and care; however, women’s voices are 
rarely captured in this research. 
Objectives: This study aimed to understand the lived experiences of women in larger bodies 
who access and use female-oriented contraception in Ontario. Specifically, this study examined: 
(1) How is contraceptive use embodied by women in larger bodies; (2) How do women in larger 
bodies navigate contraceptive care; and (3) How can women in larger bodies’ experiences with 
contraception be improved? 
Methods: This phenomenological study explored the lived experiences of 19 women in larger 
bodies who accessed and used female-oriented methods of contraception in Ontario within the 
last five years. In-depth interviews were conducted with participants and the data were analyzed 
by applying a feminist lens to interpretive phenomenological analysis. 
Results: There was significant diversity in women in larger bodies’ lived experiences with 
contraception. The notion of control was central to participants’ embodied experiences with 
routine contraceptive use, whereas experiences with contraceptive care were shaped by feelings 
of (dis)empowerment. While many participants felt supported in some capacity, women in larger 





Finally, three major stages of participants’ experiences with emergency contraception were 
detailed, revealing the significance of personal context in shaping their surrounding experiences. 
Conclusion: This study highlights the complexity and diversity of women in larger bodies’ lived 
experiences with routine and emergency contraception. The findings suggest that non-
judgemental, patient-centred approaches to contraceptive counselling and care are needed to 
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Chapter 1: Introduction 
 Family planning is considered to be one of Canada’s most significant public health 
achievements (1). Contraception plays a key role in family planning, as it enables women to 
control their fertility and plan pregnancies (2). In 1960, the approval of the first oral 
contraceptive pill (OCP) in the United States marked a major milestone in women’s rights and 
helped pave the way for the women’s movement for reproductive autonomy and sexual 
liberation throughout the decade (2,3). Following the decriminalization of contraception in 1969 
(4), Canadian society has been shaped by changes in family size, expansion of women’s 
educational and professional opportunities, strides made towards gender equality, and overall 
improved quality of life (3,5). The reproductive justice movement continues to advocate for 
marginalized populations by connecting reproductive rights with social justice when approaching 
issues related to sexual health (6).  
 There is a growing interest in examining the reproductive health care experiences of 
women in larger bodies (7–14). In 2020, approximately half of Canadian women between 18 and 
49 years of age reported a body size characterized as “overweight” or “obese” based on body 
mass index (BMI) classification (15). Having a larger body size may impact women’s 
reproductive health across the lifespan, as higher BMI is believed to contribute to menstrual 
cycle abnormalities, fertility issues, pregnancy complications, and certain reproductive cancers 
(16–18). Some studies have further indicated that higher BMI is associated with reduced 
contraceptive efficacy (19,20) and increased rates of unintended pregnancy (21). While 
individuals in larger bodies have frequently described negative or stigmatizing reproductive 
health care experiences (7,9–13), much of this literature focuses on pregnancy and therefore 





 Unfortunately, clinical contraceptive research has regularly excluded women with higher 
BMIs (20), and while a recent scoping review proposed that women in larger bodies may have 
unmet contraceptive counselling and care needs, women’s perspectives were often noticeably 
absent from the literature (22). Using qualitative inquiry, this study seeks to understand women 
in larger bodies’ lived experiences with contraceptive use and care. This thesis contextualizes 
and builds upon the current body of knowledge by uplifting women’s voices and suggesting how 
they can be better supported. In doing so, the recommendations derived from this research 














Chapter 2: Literature Review 
2.1 Contraception  
 In 2019, more than 70% of all women of reproductive age (15 to 49 years) in Canada 
were estimated to have used contraception (23). In addition to fertility control, contraception 
may be used for a variety of other reasons, such as sexually transmitted infection (STI) 
prevention, menstrual cycle regulation, reducing the risk of gynaecological cancers, as well as 
treating menstrual symptoms and conditions (24). Several different contraceptive methods are 
available in Canada for routine or emergency use, nearly all of which are designed for female 
anatomy and physiology (i.e., female-oriented) (4).  
2.1.1 Methods of Contraception 
 In general, contraceptive methods may be categorized as hormonal, non-hormonal, 
natural, and emergency contraception (25). Modern contraceptives can also be broadly 
distinguished by their short-acting, long-acting, or permanent function (23). Hormonal methods 
are among the most effective routine contraceptives and are prescribed by health care providers 
(26,27). Hormonal contraception is typically short-acting and includes methods such as OCPs, 
contraceptive injections, patches, and vaginal rings (23,26). OCPs are the most common method 
of female-oriented contraception in Canada, estimated to be used by nearly 30% of women of 
reproductive age (23) and previously reported by over 50% of young women aged 15 to 24 years 
during their most recent heterosexual encounter involving vaginal intercourse (28). In 
comparison, long-acting reversible contraception (LARC) refers to highly effective hormonal or 
non-hormonal contraceptive devices (e.g., intrauterine device [IUD]) that are inserted by health 





system, also known as the levonorgestrel-releasing IUD (LNG-IUD); the copper-bearing IUD 
(Cu-IUD) is the only non-hormonal LARC (25,26).  
 Non-hormonal barrier and natural contraception are less effective than short-acting 
hormonal and LARC methods (29). Non-hormonal barrier methods of contraception are short-
acting and include internal or external condoms, spermicide, diaphragms, prescribed cervical 
caps, and contraceptive sponges, whereas natural contraception involves behavioural techniques 
such as fertility awareness and withdrawal (23,25). Finally, permanent contraception refers to 
highly effective surgical procedures such as vasectomy, as well as tubal ligation or occlusion 
(25,29).  
 Emergency contraception is used to prevent pregnancy after unprotected sexual 
intercourse or when routine contraceptives may have failed (25,30). The main methods of 
emergency contraception include emergency contraceptive pills and the Cu-IUD (31). The Cu-
IUD is believed to be the most effective method, followed by ulipristal acetate (UPA-EC), 
levonorgestrel (LNG-EC), and lastly, high doses of OCPs (i.e., Yuzpe method) (32). Emergency 
contraception is generally most effective when initiated as soon as possible within the first 72 
hours following unprotected sex (32).  
 Apart from the approval of UPA-EC (e.g., ella®) as a prescription drug in 2015 (33), 
emergency contraception has been available in Canada for many years (34). LNG-EC is the most 
commonly used emergency contraceptive (e.g., Plan B®) and is widely available without a 
prescription (25,30). According to the 2015-2016 cycle of the Canadian Community Health 
Survey, one-tenth of sexually active Canadian women between 15 and 24 years of age reported 
using emergency contraceptive pills in the last year (28). The prevalence of lifetime emergency 





2.1.2 Provision of Contraception  
 Canada is the only country with universal publicly funded health care that does not 
include pharma care (35). At the federal level, Health Canada is responsible for approving and 
regulating contraception (5). Prescription coverage is delivered at the provincial level as a mix of 
government and private insurance plans that differ between and within the provinces and 
territories (35). In addition, the cost of female-oriented contraception varies greatly (36). While 
non-prescription barrier methods may cost between $4.00 and $30.00 per unit, prescription 
methods can range from $11.00 to upwards of $300.00 each (36).  
 Across Canada, Ontarians had the lowest out-of-pocket prescription drug expenses in 
2017, with nearly 90% of prescription drug costs covered by public or private drug plans (35). 
Ontario has several publicly funded prescription programs for individuals with a valid Ontario 
health card, including Ontario Health Insurance Plan Plus (OHIP+) for residents under 25 years 
of age without private insurance and the Trillium Drug Plan for Ontarians with high prescription 
costs relative to their household income (37,38). These plans may provide partial or full coverage 
for over 50 generic and brand-name contraceptives, such as OCPs and LNG-IUDs, through the 
Ontario Drug Benefit program (39). In comparison, private insurance plans (i.e., through full-
time employment benefits) typically cover up to 80% of prescription costs and do not always 
include contraception (40). Furthermore, women are less likely to be insured by private drug 
plans due to their overrepresentation in part-time and contract employment positions (35). Based 
on this information, while some women in Ontario are eligible to receive prescription 





2.1.3 Barriers to Contraception 
 There are various individual and system level barriers that may interfere with women’s 
ability to access high-quality contraceptive care and use contraception in a consistent manner 
(5,41). Such barriers may relate to cost, sexual health education, health care provider knowledge 
or practices, and access to primary care (41). With respect to emergency contraception, patient-
centred barriers may be attributed to the perceived risk of pregnancy, method awareness, as well 
as stigma and social concerns related to confidentiality or judgement (42–46). Information gaps 
and misconceptions may also exist regarding mechanism of action, availability, effectiveness, 
and side effects (43–46). To exemplify this, some women in Canada mistakenly believe that 
emergency contraception is an abortifacient (45,46). Additionally, health care providers may 
have incorrect, insufficient, or outdated emergency contraception knowledge and practices 
(34,47–49). For instance, a study of Ontario pharmacists revealed that approximately half of 
participants stored LNG-EC behind the counter despite its over-the-counter status (34). While 
many pharmacists reported doing so to promote counselling, they did not necessarily recognize 
how this practice may impede access to emergency contraception (34). These barriers underscore 
the need for improved provider practices and increased knowledge among women and health 
care providers alike.  
 Overall, some Canadian women may have unmet contraceptive needs. In particular, 
Indigenous women, northern or rural residents, youth, new immigrants, and women with low-
income are believed to face unique challenges when accessing and using family planning 
services (41,50). It is also important to acknowledge that the ongoing SARS-CoV-2 (COVID-19) 
pandemic has created exceptional circumstances that may further limit access to contraception, 





research has suggested that women in larger bodies may face barriers to contraceptive use and 
care (22); however, this topic has not been assessed in the Canadian context.  
2.1.4 Women’s Experiences with Contraception  
 As previously noted, contraception has become a symbol of female sexual liberation and 
autonomy (3). However, by feminizing contraceptive counselling and use, the burden of 
pregnancy prevention is often placed on women and their bodies (52–54). According to Bertotti 
(55), “fertility work” is similar to other forms of domestic labour, as it requires women to 
dedicate time while their bodies bear the physical and emotional responsibilities of using 
contraception. Therefore, women’s agency to control their fertility may be at odds with the 
burden and responsibility of using contraception (52,53). 
 Women have articulated the importance of finding a method of routine contraception that 
is a good fit for their personal circumstances and bodies (54,56–58). For many women, finding a 
good fit requires awareness of different contraceptive options, which is closely related to 
exposure to information and education (54,56,57,59–61). As such, women have previously 
expressed a desire for comprehensive, patient-centred contraceptive counselling to empower 
them to select a method of contraception that fits their individualized needs (61,62). Keeping this 
in mind, there are many factors that women may consider during contraceptive decision-making, 
such as method properties (e.g., efficacy, side effects, convenience), availability, cost, and a 
variety of personal considerations (56–58,60,61,63). For example, some women may consider 
their partners’ preferences, whereas others may value embodied knowledge from other women, 
health care providers, or their own experiences (53,59,61,63,64). Women may also associate 
contraceptive methods with certain identities, such as the vaginal ring as an “in between” 





 Upon initiating use, contraceptive (dis)satisfaction has been discussed with regards to 
women’s embodied experiences of side effects (54,58). Embodiment refers to the dynamic 
relationship between one’s felt and lived experiences within the body, highlighting how the body 
is simultaneously shaped and experienced as a subject of being (66). Women have described the 
value of non-contraceptive benefits, such as menstrual regulation or acne control (58,67). 
However, the literature has more often cited women’s dissatisfaction with undesired side effects 
(54,58,67–69). For instance, women have reported feeling “fat” or “crazy” when using hormonal 
contraception, which negatively impacted their self-esteem and personal relationships (67). 
Contraceptive users have also interpreted their embodied experiences with undesired side effects 
as a lack of bodily control, which often prompted method discontinuation (58,67,68). These 
findings suggest that women may ultimately prioritize bodily control over reproductive control 
(68).  
 Unfortunately, women still face and internalize stigma surrounding their sexual and 
reproductive health, including contraceptive use (50,61,70). Specifically, several studies have 
reported stigma associated with emergency contraception, and women have described feeling 
judged or embarrassed when accessing this care (44,45,71–74). Women have expressed a range 
of emotions following the use of emergency contraception, including relief, anxiety, and 
conflicting feelings (45,74). For some women, emotional turmoil or discomfort lingered until 
their next menstrual cycle began (74). This research suggests that the embodied experiences of 
emergency contraceptive use might be distinctively different from routine contraceptive 
experiences, as women may internalize emergency contraception-related stigma in addition to 





2.2 Larger Bodies 
2.2.1 Conceptualization of Larger Bodies 
 As I broadly refer to “larger bodies” throughout this thesis, it is essential to consider how 
larger bodies are conceptualized. While terms such as “overweight” and “obese” are not 
universally defined, they are most commonly characterized by BMI (75), a ratio of body weight 
in kilograms to height in metres squared wherein “overweight” refers to a BMI > 25, and 
“obese” as a BMI > 30 (76). However, BMI is an imperfect measurement that risks inaccurate 
classification because it fails to assess body composition and does not account for population 
variance (e.g., ethnicity, age) (77,78). As such, some researchers have advocated for moving 
beyond BMI classification in favour of more comprehensive approaches to characterize body 
weight status (77,78).   
 Although living in a larger body has long been perceived as a personal problem caused 
by individual-level behaviours, there is now a greater emphasis on approaching obesity from a 
systems perspective (79). For instance, Obesity Canada recently published clinical guidelines 
that conceptualize obesity as a multifactorial complex chronic disease and provide 
recommendations for reducing weight bias in clinical practice (80). This approach reflects 
research that has identified how “upstream” factors, such as biology, genetics, as well as 
physical, socio-cultural, economic, and political environments, contribute to body weight 
(81,82). In addition, fat activists situate weight bias and the “war on obesity” as feminist and 
social justice issues shaped by stigma, fatphobia, and intersectional systems of oppression, 





 My own conceptualization of larger bodies is consistent with feminist social 
constructionism, whereby I believe that bodies are both corporeal and figurative, as they are 
constructed in physical and cultural contexts (86). I further believe that one’s self-perceptions 
and bodily subjectivities are shaped and established by the current cultural messaging, beliefs, 
and meanings prevalent in society (87). In keeping with these beliefs, I conceptualize larger 
bodies and terms such as “overweight” and “obese” to be socially constructed and value-laden, 
reflecting a body size or weight that is above the norm of current Western standards (87). As 
such, my definition of larger bodies moves beyond BMI classification and considers that if one 
perceives their body to be larger than the societal norm, their interpretation of their experiences 
will reflect this. This conceptualization of larger bodies is used throughout this study. 
2.2.2 Weight Stigma: Embodiment and Reproductive Health Care Experiences 
 Weight stigma is the social devaluation or rejection of bodies that differ from the 
standards set by societal norms (88). This stigma may include negative stereotypes, attitudes, or 
acts of discrimination towards individuals who are considered “fat,” “overweight,” or “obese” 
(89). Some research proposes that women are disproportionately affected by weight stigma, 
which is globally prevalent throughout the media, personal relationships, as well as in health, 
education, and employment settings (84,90). Weight stigma has been particularly rampant 
throughout the COVID-19 pandemic, as demonstrated by the widespread use of social media 
hashtags like “#quarantine15,” messages related to high-risk populations, and the vilification of 
people in larger bodies for “purging” the health care system (91,92). Weight stigma represents a 
significant public health concern, as anti-fat attitudes and discrimination impair the quality of 
care that individuals in larger bodies receive, contribute to the delay or avoidance of health care, 





 Research indicates that some individuals in larger bodies feel defined by their bodies and 
alienated from others (96–99). Larger bodies have previously been embodied as objects, wherein 
individuals have become estranged from and within their bodies (99–101). For example, 
individuals in larger bodies may be hypervigilant of their bodies or feel that they are under 
constant public surveillance, resulting in self-scrutiny, concealment, or body avoidance (96,99–
101). To illustrate this, some women in larger bodies have described attempting to “compensate” 
for their weight by focusing on enhancing their personas, whereas others have tried to mask their 
bodies through clothing or posture (98,100,101). Moreover, a recent study demonstrated how 
weight stigma can become embodied when behaviours are assigned moral value, as participants 
wrongly predicted weight gain and described feeling heavier after engaging in “bad” conduct 
(e.g., consuming food with high caloric value) (102). In comparison, women in larger bodies 
who engage in body acceptance have reported improved body image and more satisfying sexual 
experiences (103). These embodied experiences suggest that weight stigma, as well as the 
physical and lived bodies, are intrinsically linked.  
  Weight stigma is well-documented in health care (93,94) and impacts women across the 
reproductive health continuum (10,11,14,104). Women in larger bodies have often described 
feeling shamed or embarrassed during reproductive health care visits (7,9–12,14). For example, 
individuals who were labelled as “overweight” or “obese” when seeking fertility or prenatal care 
in Ontario described how their bodies were problematized and scrutinized by health care 
providers, which detracted from the quality of their care (9). Furthermore, an American study 
found that a lack of size-appropriate equipment, uninvited weight-loss advice, and disrespectful 
treatment by health care providers were all associated with delaying or avoiding reproductive 





maternal health care experiences (7,9–13), some women have valued health care providers who 
“looked beyond the scale” and made them feel heard, cared for, and “seen behind the fat” (8,11). 
Overall, the current body of knowledge indicates that women in larger bodies may face 
significant challenges when accessing and using reproductive health care services. 
2.3 Contraception and Women in Larger Bodies 
 Despite some evidence that sexual activity is similar across weight categories (105), 
clinical research on contraception has typically focused on a relatively small range of body sizes 
(20). There is also little known about women in larger bodies’ lived experiences with 
contraception, as the literature on this topic is predominantly quantitative (22). While limited, the 
current body of knowledge provides insight on contraceptive efficacy and safety; patterns of use 
among women in larger bodies; contraceptive decision-making and factors that may influence 
(non)use; and contraceptive counselling provided to women in larger bodies. 
2.3.1 Efficacy and Safety  
 The impact of body size on contraceptive efficacy and safety remains under-studied and 
poorly understood (20,106). Although the findings are mixed (107), there is limited research 
supporting the reduced efficacy of certain contraceptives among women with higher BMIs, such 
as the contraceptive patch (20,108). Furthermore, combined hormonal contraceptives (e.g., 
combined OCP [COC] containing estrogen and progestin) may be contraindicated due to an 
elevated risk of thromboembolic and cardiovascular events (106). The current safety and 
efficacy-based research evidence thus indicate that progestin-only hormonal contraceptives (e.g., 





 The Cu-IUD remains the most effective method of emergency contraception for women 
of all body sizes (109). Regardless of its popularity, LNG-EC may have reduced efficacy when 
used by women with higher BMIs (19). Limited data also suggest that UPA-EC may be less 
effective for women in larger bodies, albeit these findings are statistically insignificant (19). As 
of 2014, all Canadian LNG-EC packaging must include a warning of reduced efficacy among 
women who weigh over 165 pounds and ineffectiveness in women who weigh over 176 pounds 
(110). Although emergency contraception should not be discouraged based on body size, when 
possible, the Society of Obstetricians and Gynaecologists of Canada (SOGC) recommends UPA-
EC as the emergency contraceptive pill of choice for women with a BMI > 25 and the Cu-IUD 
for women with a BMI > 30 (111). Nonetheless, women in larger bodies should still be 
counselled on all methods of emergency contraception to make an informed decision (20). 
2.3.2 Patterns of Contraceptive Use  
 Consistent with data from the general population of Canadian women at risk of 
pregnancy (112), OCPs are often the most commonly reported method of female-oriented 
contraception used by women in larger bodies (22). However, numerous studies have shown that 
women with higher BMIs may be more likely than women within the “normal” range (i.e., BMI 
18.5 to 24.9) to use LARCs or undergo tubal ligation and less likely to use other hormonal 
contraceptives (113–118). While these findings seem to suggest that women in larger bodies use 
more effective methods of contraception, some findings indicate that this population may also be 
more likely to rely on less effective methods, discontinue new prescriptions, or not use any 
contraception (113,115,117,119,120). 
 There is a scarcity of research on women in larger bodies’ experiences with emergency 





UPA-EC from American women with a BMI > 30 increased significantly after weight warnings 
were temporarily added to European LNG-EC labels in 2013 (121). Based on the findings from a 
search engine scan of “emergency contraception effectiveness weight” completed before and 
after the advisory was introduced, the researchers proposed that this shift may, in part, reflect the 
increased information available online (121). Similarly, data from a national survey conducted in 
the United States between 2013 and 2015 revealed that fewer than one-third of women who 
reported LNG-EC use in the last year also reported a height and weight characterized by a BMI > 
26 (122). Further research is needed to better understand the contraceptive practices of women in 
larger bodies and how they interpret information pertaining to weight-related efficacy (22,121). 
2.3.3 Contraceptive Decision-Making and Factors Influencing (Non)Use 
 When selecting a method of contraception, women in larger bodies may consider factors 
such as side effects and ease of use (114,123–125). For instance, a focus group study revealed 
that women in larger bodies were concerned about weight gain that may accompany the use of 
hormonal methods (125). While these participants did not believe that their weight limited their 
contraceptive options (125), findings from another study suggested that women in larger bodies 
may consider LNG-EC’s weight-related efficacy when selecting UPA-EC (121). Finally, method 
dissatisfaction and side effect profile may also prompt women in larger bodies to discontinue use 
or seek a new contraceptive method (120,126), which is consistent with the broader literature on 
women’s experiences of contraceptive side effects and decision-making (54,58,67,68). 
 In addition, personal, provider, or access barriers may limit women in larger bodies’ use 
of contraception (22). Women with higher BMIs who do not use contraception have previously 
reported perceived subfertility (117,124,126,127) and researchers have suggested that access or 





contraception (116,120,126). Finally, some researchers have implied that perceptions of stigma 
or low self-esteem may deter women in larger bodies from seeking contraceptive care 
(113,117,119).  
 While one study found that women in larger bodies were less likely than their lower BMI 
counterparts to report recently accessing contraceptive care (113), the proposed barriers noted 
above have not yet been formally examined. However, anecdotal evidence from medical weight 
stigma studies indicate that women in larger bodies may encounter weight discrimination related 
to contraceptive use (7,10,128). In 1990, Packer (128) found that several women with higher 
BMIs struggled to access contraception because their gynaecologists held prejudiced attitudes 
that they were not sexually active (128). More recently, two Canadian women reported 
prolonged LARC use because their health care providers refused to remove their contraception 
(7,10). While one woman’s delayed LNG-IUD removal was related to her doctor’s unwillingness 
to perform a Papanicolaou (Pap) test due to her weight (7), another woman was repeatedly 
denied her reproductive rights because her doctor believed that pregnancy would be a “disaster” 
at her size, resulting in emotional trauma that induced distress when she subsequently sought 
care from another health care provider (10).  
2.3.4 Contraceptive Counselling Provided to Women in Larger Bodies 
 Contraceptive counselling helps women select a method of contraception that they can 
use confidently and correctly (129). Counselling appears to positively influence contraceptive 
decision-making among women in larger bodies, as it is associated with choosing highly-
effective methods of routine contraception, such as LARCs (123,124,126,127,130). Yet, women 
with higher BMIs may receive inadequate contraceptive counselling (120,123,124,126,127,130–





larger bodies who reported ever receiving contraceptive counselling could, in part, reflect weight 
bias among health care providers.  
 Contraceptive counselling may not always be effective. Two studies reported that women 
in larger bodies were prescribed or accessed COCs despite contraindications and guidelines, 
which could suggest poor provider counselling and care (120,132). Similarly, researchers have 
proposed that health care providers may focus on other aspects of women in larger bodies’ health 
care or have insufficient time to discuss relevant weight-related considerations during 
contraceptive counselling (114,119). In addition, there may be inconsistencies in the emergency 
contraceptive counselling and care provided to women in larger bodies. A greater proportion of 
American LNG-EC users with a BMI > 26 reported recent emergency contraceptive counselling 
when compared to users with lower BMIs (~ 40 vs 18%, respectively) (122). While it is unclear 
what information was provided during this counselling, given that LNG-EC may have lower 
weight-related efficacy, these findings could indicate outdated provider knowledge or barriers to 
accessing more effective methods of emergency contraception (122). In contrast, Cleland et al. 
(121) found that multiple women in larger bodies reported that a health care provider had 
advised them to seek UPA-EC instead of LNG-EC based on their weight. Although some 
Ontario pharmacists may routinely discuss weight with emergency contraception clients (34), 
others have reported feeling uncomfortable doing so (49). To illustrate this, Vogel (133) shared 
her unsettling experience purchasing LNG-EC from one Canadian pharmacist without any 
discussion after being refused Plan B® at a different pharmacy due to her body size. Overall, the 
current literature suggests that women in larger bodies may have unmet contraceptive 
counselling needs; therefore, there is a need to examine these women’s experiences and capture 






 In summary, there are several methods of contraception available in Canada for routine or 
emergency use. Women are often the users of contraception and try to find a method that is a 
good fit for their individualized needs, but may encounter unwanted side effects and various 
personal, provider, or systemic barriers. Women in larger bodies remain a significant yet under-
researched population of contraceptive users. Apart from a few options, many methods of 
contraception are believed to be safe and highly effective for women in larger bodies. While the 
current body of knowledge suggests that these women may face unique challenges and receive 
inadequate contraceptive care, women in larger bodies’ voices are rarely centred in contraceptive 
research. To date, there is a glaring lack of qualitative studies focused on women in larger 
bodies’ lived experiences with contraception and a dearth of Canadian research on this topic. 
Considering this gap, the perspectives of women in larger bodies who access and use 
contraception are needed to better characterize this population’s experiences with contraception 










Chapter 3: Study Objectives 
 This research examined the following question: “What are the lived experiences of 
women in larger bodies who access and use female-oriented contraception in Ontario?” To 
answer this question, I also addressed the following sub-questions:  
1) How is contraceptive use embodied by women in larger bodies? 
2) How do women in larger bodies navigate contraceptive care? 
3) How can women in larger bodies’ experiences with contraception be improved? 
These research questions aimed to provide a greater understanding of women in larger bodies’ 
lived experiences with contraception and contraceptive care, the meanings they ascribed to their 











Chapter 4: Methods 
4.1 Research Design 
 Qualitative research aims to understand a particular phenomenon from the perspective of 
those being studied (134). Given the notable lack of qualitative research exploring women in 
larger bodies’ experiences with contraception and contraceptive care, this study adopted a 
qualitative methodology to address the research questions stated in Chapter 3. Using a 
phenomenological approach, I conducted 19 in-depth interviews with women in larger bodies 
who accessed and used female-oriented methods of contraception in Ontario within the last five 
years.  
4.2 Theoretical and Methodological Orientation 
 To focus on the meaning of women in larger bodies’ lived experiences, an interpretive 
phenomenological approach with a feminist lens was adopted. Phenomenology is a qualitative 
research approach, methodology, and philosophy that studies the meaning of embodied human 
phenomena by considering how individuals make sense of their experiences (134–136). There 
are two major schools of phenomenology: descriptive and interpretive (135). While descriptive 
phenomenologists describe key features of phenomena, interpretive approaches aim to uncover 
and interpret meanings hidden in ordinary life (137).  
4.2.1 Interpretive Phenomenology 
 Also known as hermeneutic phenomenology, interpretive phenomenological approaches 
use evolving methods to allow researchers to explore nuances in the data and remain open to new 
understandings (138). To do this, researchers seek to examine unexplored or overlooked 





lifeworld, which refers to how individuals’ realities are indubitably and fundamentally shaped by 
the contexts in which they live (137,139). Hermeneutic phenomenologists interpret phenomena 
and experiences through the lifeworld, thus considering the influence of an individual’s personal 
history and social identities in shaping their experiences (139).  
4.2.2 Role of the Body 
 Phenomenology is closely related to the concept of embodiment, which can be traced 
back to the works of Merleau-Ponty (140). Phenomenologists consider the body to exist in terms 
of the lived and physical bodies (141). While the biological sciences can describe the physical 
body, the lived body is central to human experiences (141). For instance, experiences are 
grounded in literal and metaphorical “bodies of meaning,” through which the body is interpreted 
and embodied actions hold significance (66). As such, embodiment can be explained as a lived 
process that shapes one’s self-concept and understanding of others (66). Moreover, reflexive 
embodiment refers to the dual existence of the body as a state of being and, on occasion, an 
object of possession (142). Embodiment has been used to describe the experiences of individuals 
in larger bodies (100–102) and women’s experiences with contraception (54,58,64), and was 
considered throughout my analysis. 
4.2.3 Feminist Lens 
 Given the feminization of contraceptive use (52–54) and to appreciate participant 
diversity, pay attention to social inequalities, and be mindful to notions of stigma, I approached 
my research with a feminist lens (83). Researchers have previously investigated the gendered 
experiences of weight, whereby the concept of “fatness” has often been feminized (83,98,143). 





also examining issues related to power and otherness (134). Similarly, the experiences of 
individuals in larger bodies can be understood in relation to reduced social power (83). 
According to Calogero, Tylka, and Mensinger (83), a feminist lens can be used to illuminate the 
nuanced forms of bias and oppression faced by individuals in larger bodies. Further, this lens 
provides a holistic understanding that “fat” identities and experiences are highly individualized 
and cannot be separated from one’s other social identities (83). Thus, the feminist lens 
strengthened my analysis by challenging me to think critically about each participant’s identities, 
how their experiences were constructed, and the ways in which their positionality influenced 
how they understood these experiences.  
4.3 Study Sample, Recruitment, and Data Collection 
4.3.1 Study Sample and Eligibility  
 Participation in this study was open to women over 18 years of age who met the two-
pronged eligibility criteria. Firstly, participants had to identify as living in a larger body. 
Secondly, participants must have accessed and used female-oriented routine and/or emergency 
contraception in Ontario within the last five years. These eligibility criteria were chosen to 
reflect the study goals and to account for relevancy within the Canadian context with respect to 
the introduction of the weight advisory on LNG-EC labels (110), the market approval of UPA-
EC (33), and for recruitment purposes.  
4.3.2 Recruitment  
 Participants were recruited by sharing the study poster and website (see Appendices A 
and B) on social media profiles, groups, and other online platforms (e.g., Kijiji). Snowball 





and study information to reach individuals within their social networks who may have been 
interested in participating. All recruitment materials provided a project description, outlined the 
inclusion criteria, emphasized that participation was voluntary, and listed my contact 
information. 
 I took a staggered approach to recruitment by evaluating participant uptake every few 
weeks before planning to share recruitment materials further (e.g., in a new Facebook group). 
Participants were asked to confirm how they learned about the study to track recruitment 
success. Of note, several participants offered information about other groups, organizations, or 
platforms where recruitment could be shared for greater visibility. Although few of these 
avenues were explored due to ample interest in participation, the suggestions were greatly 
appreciated and demonstrated participants’ excitement about this research. When someone 
contacted me to express interest in participating, they were sent a letter of information and 
consent form via e-mail to review the study eligibility, processes, and procedures (see Appendix 
C). Upon confirmation, interviews were scheduled with individuals who wished to participate.  
4.3.3 Data Collection 
 Each interview was arranged at a date, time, and platform selected by the participant. 
Thirteen interviews took place online via videoconference (e.g., WhatsApp, MS Teams, Zoom), 
and six participants preferred to connect by telephone. Unstable Internet or telephone connection 
sometimes posed a challenge, and, as a result, one participant’s interview took place over the 
span of two different days. Prior to beginning each interview, I addressed all inquiries, obtained 
verbal consent to participate in the study (see Appendix D), and offered participants the 





 Consistent with phenomenology, participants took part in in-depth interviews (137). 
Guided by broad questions, the in-depth approach allowed participants to discuss what was most 
important to their experiences, which in turn enabled me to gain a comprehensive understanding, 
capture unique perspectives, and explore interesting or unanticipated responses (134,145). The 
interviews began with a general introductory question that asked participants to describe 
themselves. At this time, I also collected demographic information pertaining to participants’ 
age, ethnicity, location (e.g., rural or urban), education level, and sexual orientation. This 
information helped me explore participants’ social identities and examine how individual 
experiences may have varied by social context. The rest of the interview focused on participants’ 
lifelong experiences accessing and using contraception to understand how women in larger 
bodies felt about their experiences with contraceptive use, how they perceived their 
contraceptive counselling and care, and the meanings that participants ascribed to these 
experiences. Reflecting on their experiences, participants were also asked to compare 
contraceptive care to other health care and suggest how their experiences could be improved in 
the future. The complete interview guide can be found in Appendix E. 
 Interviews were conducted between November 2020 and February 2021. The length of 
the interviews ranged from 36 minutes to nearly four hours, with most interviews lasting 
between 1.5 and two hours. All interviews were audio-recorded with participant permission and 
transcribed verbatim. Participants were offered a copy of the results upon study completion.  
4.4 Ethics and Considerations 
 This study received ethics clearance from the University of Waterloo Office of Research 
Ethics (ORE #42481). Prior to beginning each interview, I spoke with participants for a few 





By building rapport, I hoped to help participants feel more relaxed, establish trust, and promote 
sharing (134). In addition, the interview questions were constructed to be open-ended to facilitate 
a conversational dialogue where participants could share their experiences candidly (145,146).  
 Some participants shared upsetting experiences during the interviews. While participants 
often assured me that they felt comfortable discussing these experiences, in other instances, I 
asked permission before posing follow-up questions. In consideration of participants’ feelings, I 
was attentive to body language, tone of voice, and offered to pause the interview if I sensed that 
a participant was upset. Along with a feedback letter to thank them for their participation (see 
Appendix F), participants were made aware that an information page with community resources, 
supports, and services was available if desired (See Appendix G). 
4.5 Participants 
 Nineteen participants took part in this study. A detailed description of each participant’s 
demographic information and contraceptive history can be found in Table 1 at the end of this 
section and Appendix H, respectively. Participants were between 23 and 39 years of age, with 
most being in their twenties (n=11). The majority of participants identified as heterosexual or 
predominantly heterosexual (n=13), exclusively white (n=12), and urban dwelling (n=16). This 
sample was highly educated, with all participants having attended at least some post-secondary 
education, four of whom had attained a Master’s degree. While all participants identified in some 
way with the term “woman” by nature of the inclusion criteria, one participant stated that they 
were not cis-gender, but rather identified as “femme.” Although I did not confirm participants’ 
pronouns, this participant indicated that they use they/them pronouns and thus, the language used 





 It is further worth remarking that many participants disclosed other intersecting aspects of 
their identities throughout the interviews. For instance, a number of participants noted their 
mental health disorders (n=8), religious backgrounds (n=5), sexual inactivity (n=3), and 
immigration status (n=1). Many participants disclosed medical condition(s) (n=14), the majority 
of which included a diagnosed gynaecological condition that impacted menstruation, such as 
polycystic ovarian syndrome (PCOS), endometriosis, or adenomyosis (n=8). Finally, many 
participants reported having access to private or public insurance at some point throughout their 
experiences (n=15), but some admitted that cost became a concern or barrier to routine 
contraceptive use when they were uninsured (n=4). Similarly, some participants also described 
instances where they did not use emergency contraception, in part, due to the price (n=4). 
 Within the sample, 10 participants had a history of both routine and emergency 
contraceptive use, eight participants had just used routine methods, and one participant had only 
ever used emergency contraception. Among the 18 participants who had experience with routine 
female-oriented contraception, methods used included OCPs (n=17), LNG-IUD (n=6), vaginal 
ring (n=4), contraceptive injection (n=2), Cu-IUD (n=1), and incidentally, tubal ligation (n=1) 
and spermicidal film (n=1). As the spermicidal film was only used on a single occasion, female-
oriented non-hormonal barrier methods of contraception were largely underrepresented in this 
study sample. All but two women in larger bodies who ever used emergency contraception had 
multiple experiences doing so (n=9). In addition to LNG-EC (often Plan B®), one participant 
was once prescribed two oral medications as an alternative emergency contraceptive pill. None 
of the participants had used UPA-EC or a Cu-IUD for emergency contraception. Aside from 





condoms and one participant described using dental dams and nitrile gloves to protect against 
STIs. 
 Twelve participants were using hormonal contraception at the time of the interview. Of 
note, all current users were able to access their contraception since the beginning of the COVID-
19 pandemic, and while some participants received virtual and/or in-person contraceptive care 
during this time (n=5), a few others stated that their care had been delayed or avoided (n=2). 
Four women were only using external condoms, one participant was prescribed an endometriosis 
medication that acted similarly to an OCP, and as previously mentioned, another had a tubal 
















Table 1. Participant demographics  










23 White Urban Bachelor  Heterosexual 
Antara 
 
32 Indian Urban Bachelor Bisexual 
Barbara 23 Egyptian-
Latina 
Urban Bachelor Heterosexual 
Beyoncé 24 Jamaican-
Filipino 
Urban Bachelor Heterosexual 
Gia Grace 
 
33 White Urban Bachelor Heterosexual 
Gwen 26 White 
 
Urban Bachelor Unsure 





31 White Urban Master Heterosexual 
Lilieae 
 
31 White Urban Bachelor Heterosexual 
Luna 
 
24 White Urban Master Bisexual 
Marie 31 White-Latina 
 
Urban Bachelor Heterosexual 
Mavis 26 Trinidadian- 
Brown 
Urban Bachelor Heterosexual 





39 White Urban College Predominantly 
heterosexual  





23 White Rural Bachelor Queer 
Steph 
 
26 White Rural Master Heterosexual 













4.6 Data Analysis 
 Data analysis was guided by Smith and Osborn’s (146) interpretive phenomenological 
analysis (IPA). This iterative analytic method provides clear guidelines and focuses on 
understanding the meaning of participant experiences (146). As previously noted, I applied a 
feminist lens to my analysis to pay particular attention to inequalities that may have shaped 
participants’ lived experiences. 
 Preliminary analysis began by taking notes during the interviews to capture key topics 
and interesting experiences to explore further. Following each interview, I wrote a journal entry 
to provide a detailed summary where I reflected on the participant’s experiences and documented 
my own observations or interpretations (e.g., emotionality, technical issues, reflexivity). After 
transcribing each interview, I imported the data into NVivo-12, a data management software 
commonly used by qualitative researchers (147). The interviews were discussed with my 
supervisor on a regular basis to make analytic interpretations and propose early findings.  
 When data collection was completed, I shared all interview transcripts with my 
supervisor to verify preliminary interpretations and my subsequent analysis. Given the breadth 
and depth of the interviews, I decided to make adaptations to Smith and Osborn’s (146) analytic 
process to manage the data better. The eight steps that I took to analyze my data are as follows: 
1. Writing preliminary analytic summaries. Analytic summaries were created for each participant 
to provide a quick, contextual outline to refer to throughout data analysis and to orient myself 
before examining the complete dataset. Working with one interview at a time, I familiarized 
myself with the data by reading through the transcript several times (146). I took notes 





Once I had a good understanding of the participant’s story, I wrote a brief summary highlighting 
pivotal features of their experiences (e.g., one-half page to one page in length) and described 
three to five key themes of meaning that captured the “essence” of their experiences. I then 
moved on to the following transcript and repeated this process. When all the preliminary analytic 
summaries were completed and I felt immersed in the data, I began to individually analyze the 
transcripts more formally. 
2. Multiple reading and note revision. I again read the first transcript multiple times (146). While 
doing this, I reviewed my preliminary analytic summary and notes, expanding upon this text and 
jotting down new insights when applicable. 
3. Broad coding (Parent nodes). When I felt comfortable with the data, I coded the transcript for 
broad topical meanings to help organize the data (i.e., parent nodes). These codes were often 
similar to the interview guide topics (e.g., routine contraceptive use, health care encounters). 
4. Micro coding (Child nodes). After completing broad coding, I returned to the beginning of the 
transcript and coded succinct themes that captured the meaning of what was being said (146). 
These themes were coded within the context of the broader codes (i.e., child node as a subcode to 
the parent node), thus allowing me to distinguish and gain a deeper understanding of different 
dimensions of meaning. For example, feelings of anxiety pertained to different circumstances, 
such as when using emergency contraception, during health care encounters, or when describing 
a side effect.  
5. Memo drafting. Rather than listing all micro coded themes from the transcript, organizing 
them into higher-order themes, and tabling the results (146), I streamlined my analysis by 





acted as a second coder for the analysis of the first seven transcripts. The memo was further 
compared with the participant’s corresponding preliminary analytic summary, journal entry, and 
notes for verification.  
6. Moving on and going back. Once I completed the coding and had drafted a memo, I moved on 
to the next transcript. Steps two through five were repeated for each interview transcript.  
7. Mapping the themes. After all coding and memos were completed, I examined the dataset as a 
whole. I first grouped all the broad codes into three separate categories, which are reflected in the 
topics of Chapters 6 to 8 (e.g., embodied contraceptive use). Then, one at a time, theme maps 
were developed for each category by extracting all child nodes from the parent nodes within the 
category and connecting, grouping, and integrating them together to form higher-order themes. 
Considering the iterative nature of IPA, transcripts and coded data (i.e., participant quotes) were 
reviewed throughout the mapping process, and coding adjustments were made where necessary 
(146). Furthermore, close attention was paid not only to the depth of the data, but also to the 
participants represented in each code and theme. 
8. Translation. Major themes were prioritized in my findings in consideration of the richness of 
the data, interesting commonalities or differences among and across participants, and relevancy 
to the overall meaning of participants’ experiences (146). Codes and transcripts were reviewed to 
verify my interpretations as I translated my findings into thesis chapters. Care was taken to 
ensure that each participant was adequately represented in the findings, both in terms of themes 





4.7 Reflexivity and Positionality 
 Reflexivity is a crucial aspect of phenomenological studies, as it considers how the 
researcher influences the interpretations of participants’ lived experiences (148). IPA 
acknowledges the active role of the researcher through a “double hermeneutic,” whereby the 
researcher aims to interpret and make sense of the accounts shared by participants, who are 
trying to make sense of their own experiences and lifeworld (146). The iterative nature of IPA 
allows researchers to navigate participant experiences while also examining their own sense-
making (146).  
 I approached this research with my own attitudes, values, identities, and lived 
experiences that shaped my understanding and interpretation of participants’ stories. My 
curiosity and investment in this research topic stemmed from my passion for sexual and 
reproductive health and a close friend’s experience with emergency contraception. In addition, I 
have previously identified as living in a larger body and have a personal interest in body 
inclusivity. I engage with body liberation content (e.g., by activists, academics), which has 
helped me grow personally and academically. Nonetheless, as a young, white, middle-class, 
neurotypical, straight-sized, able-bodied, heterosexual, cis-gender woman with insurance 
coverage to support nearly ten years of consistent hormonal contraceptive use, I recognize that I 
carry substantial privilege in conducting this research and that these privileges, along with my 
positionality, impacted how I created meaning in the accounts of participants’ experiences.  
 Interpretive reflexivity moves beyond positionality statements and attempts to 
demonstrate how researchers create meaning in participants’ lived experiences (149). I 
incorporated reflexivity into my analysis by taking reflective notes when journaling after each 





commentary in the findings to explain my role in constructing meaning (150), as I immersed 
myself in this research, I became increasingly opposed to doing so as I did not wish to detract 
from participants’ accounts by highlighting my own. Nevertheless, throughout data collection 
and analysis, I often found myself reflecting upon the interviews and thinking about my own 
lived experiences with contraceptive care, use, and health care more broadly. As I am a 
contraceptive user who has previously identified as living in a larger body, my embodied 
experiences not only helped me relate to my participants in some ways, but also shaped my 
understanding and interpretation of their stories. Furthermore, my supervisor and I engaged in 
reflexive discussions wherein we considered the ways in which our own lived experiences with 
contraception were similar or different from those of my participants. While we took note of 
some similarities, such as my adolescent use of hormonal contraception for menstrual regulation, 
there were also several differences, for instance, as I have not experienced stigma when 
accessing health care. Thus, this exercise helped me to navigate and consider my role in 
influencing data collection and interpretation, while also allowing me to critically reflect upon 











Chapter 5: Participant Stories 
 There was significant diversity in the stories shared with me by women in larger bodies. 
While the interviews focused on participants’ experiences with and feelings about contraception 
and contraceptive care, the conversations varied based on the range and complexity of their 
experiences. As such, women’s stories revealed the deeply personal nature of participants’ 
journeys with contraception and health care more broadly. Acknowledging the challenge of fully 
capturing this nuanced mosaic of lived experiences in my results, this chapter will preface the 
study findings by highlighting the diverse stories of five participants. By outlining the lifelong 
relationships that participants fostered with contraception, health care providers, and their own 
bodies, I aim to create a foundation for my subsequent analysis to showcase diversity, uplift 
women’s voices, and meet participants where they are. 
5.1 Mavis 
 Mavis is an “easy-going” 26-year-old Trinidadian-Brown woman who had very few 
health care experiences growing up. Mavis learned about a variety of contraceptive methods in 
high school, including how Plan B® may be less effective for larger body sizes. She accordingly 
“went through life” knowing that she should prioritize consistent use of routine contraception. 
When Mavis was 22-years-old, she entered a committed relationship and decided to schedule an 
appointment at a young women’s health clinic to discuss initiating contraceptive use.  
 During the appointment, the doctor inquired about Mavis’ medical and sexual history, 
took her blood pressure, and requested that she complete Pap and blood tests. The doctor 
provided Mavis with “a lot of resources” and they discussed various contraceptive options 





selected OCPs, which she believed could be worked into her daily routine on a long-term basis. 
Overall, Mavis thought that her needs were “catered to” as a first-time contraceptive user; she 
felt informed and supported throughout her contraceptive care.  
 When Mavis returned to the clinic for a three-month follow up, her blood pressure was 
slightly higher and she had gained weight. The doctor gave Mavis “the clear” to continue using 
contraception, but she felt somewhat anxious knowing that her blood pressure would be closely 
monitored at each subsequent appointment. Mavis gained a total of 30 pounds within the first six 
months of use, but she “didn’t mind” it due to the positive role that contraception played in her 
relationship. In addition, OCPs regulated her “very irregular” menstrual cycle – something that 
Mavis never imagined possible.  
 Mavis was fully insured under OHIP+ until she turned 25-years-old and began paying for 
her contraception out-of-pocket. While the cost was manageable, Mavis had to change OCPs 
twice due to pharmacy supply shortages, which once left her unable to access contraception for 
five consecutive weeks. Given that her body had become “used to” OCPs, Mavis observed new 
“changes” during this time, such as prolonged bloating, migraines, and acne. Desperate for “any 
prescription that they could give [her],” she promptly accepted the pharmacist’s offer to dispense 
an available alternative brand so she could begin using contraception again. 
 When she was no longer eligible to receive care at the young women’s health clinic, 
Mavis was referred to a busy male gynaecologist. She recalled an initial “learning curve” 
because the gynaecologist was used to older patients who had more experience with Pap tests, 
but Mavis began to feel more comfortable after requesting that he be more forthcoming with her. 
While Mavis mainly saw this doctor for cervical screening, he regularly confirmed that she was 





has relocated and now sees a family doctor in her current city. Although their conversations 
about contraception have been limited thus far, Mavis feels generally satisfied with her care. 
 Overall, Mavis characterized contraceptive care as a lengthy process with several “steps.” 
In any case, she was grateful that contraception empowered her to “live [her] twenties like, kind 
of by [her] timeline” and control where her “path is going.” Although she faced some minor 
inconveniences along the way, Mavis reflected positively on her experiences:  
I feel like I was super lucky in that I was, you know, [from] the time that 
I began [using] contraception and the support that I got, both from health 
care professionals and from people in my personal life, I think, honestly, 
I’ve had a great experience with it. Regardless of whether I’m in a larger 
body, I really feel like I had a great experience with contraception from 
beginning to even now. 
Looking towards the future, Mavis plans to continue using OCPs until she and her partner are 
ready to start a family. 
5.2 Tuck 
 Twenty-four-year-old Tuck is an “outgoing” Persian-Caucasian woman who grew up in a 
religious Middle-Eastern family where she was raised primarily by her father. Tuck has had the 
same family doctor since childhood, when she “hated” going for appointments, as she explained:  
I was a fat little kid who would sit there and they would talk about me in 
front of me – about me being fat and stuff! So, there’s definitely, like, 
going to the doctor gets associated with, like, being ashamed of your 
body and, like, how you exist and stuff.  
This sense of shame carried into her adolescence, when Tuck avoided health care because she 
feared that her family doctor would initiate “scary conversations” and call her a “failure” because 
she was “still fat.” Her internalized stigma was further deepened by a discomfort with sexual and 





public school sex education. Consequently, when Tuck was a teenager, she convinced herself 
that her amenorrhoea, or absence of menstruation, was “normal.” 
 When Tuck’s father realized that he had never purchased menstrual products for his 17-
year-old daughter, he took her to a hospital and she was diagnosed with PCOS based on her 
symptoms and blood test results. Tuck was referred to a gynaecologist who told her about 
various contraceptive methods and recommended OCPs to manage her PCOS. The gynaecologist 
then explained the daily regimen, when to expect her menstrual period, and advised Tuck to let 
her know if she had any issues. Although she did not necessarily have the opportunity or desire 
to ask questions, Tuck recalled thinking: “this is what I have to take to make everything better.”  
 Contraception successfully induced Tuck’s menses and controlled her PCOS symptoms 
when used consistently. Despite characterizing herself as “doctor averse,” she always felt very 
comfortable with her pharmacist, who was a close family friend and provided additional 
information about how the OCPs worked. Tuck continued to see her gynaecologist for PCOS 
management, but her appointments often felt rushed. Much to her surprise, when she phoned the 
office to renew her OCPs a few years later, Tuck was informed that she had been discharged 
from the gynaecologist’s care and her prescription was transferred to her family doctor’s office. 
Annoyed, Tuck knew that she would eventually have to return to see her family doctor.  
 Tuck had insurance coverage, but admitted that the prescription-status of OCPs posed a 
significant personal barrier to her contraceptive care. Internalized stigma “very clearly” impacted 
how she engaged with the health care system, and Tuck described several instances where she 
made an expressed effort to continue avoiding her family doctor. Tuck usually renewed her 
prescription over the phone or with an on-call doctor at the office, but said she became “sneaky” 





I would go to, like, [a clinic] where I don’t have any history with them 
and let them know, like, “Hey, my birth control is expiring,” and 
(exhales) you know, mislead them maybe to a certain extent and say, 
“Hey, I can’t get an appointment with my family doctor for a while and I 
don’t want to be off the pill. Like, it’s a PCOS treatment that I’m on.” 
Um, and then they would write a prescription that I could get refilled 
maybe one or two more times from [them] instead of my actual doctor’s 
office because I – sometimes I wanted to avoid going to the doctor. 
 While most of the clinic encounters felt “a little rushed” and involved minimal discussion, some 
doctors asked why Tuck had not yet completed a Pap test. As she was not sexually active and 
feared being “forced” to have this exam to access contraception, Tuck sometimes felt that these 
questions involved “more prodding than maybe necessary.”  
 Tuck is now more comfortable with her body and no longer avoids her family doctor. In 
her early twenties, she became concerned that she still “knew so little” about her own body and 
started to learn more about sexual and reproductive health online. After deciding that she was 
“tired of being scared” and needed to “grow up,” Tuck vowed to overcome her internalized 
stigma and eventually scheduled an appointment with her family doctor during the COVID-19 
pandemic. Tuck has recently felt “a little icky” swallowing pills, but wanted to continue using 
OCPs because she worried that her body may not react as well to other hormonal contraceptives. 
During the virtual appointment, Tuck engaged in a “pretty one-way conversation” where she told 
her doctor about her PCOS diagnosis and management. She requested a prescription renewal for 
her OCPs along with an in-person appointment for STI screening and a Pap test, as she had 
started to engage in more sexual activity. After confirming that Tuck was content using OCPs, 
the doctor obliged and wrote a prescription without asking any further questions.  
 Tuck is grateful to have access to contraception and while she used to intentionally limit 





contraceptive care have “probably [been] lacking.” Knowing that her family doctor “won’t bring 
it up,” she plans to initiate and engage in more conversations about her sexual and reproductive 
health care in the future.  
5.3 Gia Grace 
 Gia Grace is a 33-year-old white woman who described herself as “laid-back” and well-
travelled. Throughout her life, Gia Grace sometimes felt that being a plus-sized woman was a 
“double negative” in health care, as her concerns have been questioned, dismissed, or simply 
attributed to her weight. At the end of high school, Gia Grace went to see her family doctor about 
extreme menstrual cramping. Upon stating that she tried pain relief medication to no avail and 
was missing school as a result, Gia Grace was prescribed OCPs. Her doctor briefly explained 
that contraception would alleviate her pain and improve her acne, but he provided very “vague” 
information about pregnancy prevention. Although Gia Grace was not sexually active yet, she 
wanted to be prepared and was disappointed that her doctor seemed to assume that she did not 
need that information. Regardless, Gia Grace only used OCPs for about six months before 
deciding that contraception “wasn’t for [her],” as she frequently forgot to take her pills and had 
not experienced any symptom relief. 
 Since becoming sexually active, Gia Grace has used external condoms for contraception. 
A few years ago, she was curious about IUDs and scheduled an appointment with her new family 
doctor to discuss contraception. The doctor listed several methods and gave Gia Grace a website 
link where she could find more detailed information. Despite feeling supported and informed 
throughout the appointment, Gia Grace would have appreciated personalized advice about which 
options may have been best for her. After doing her own online research and learning about other 





of information and concluded that “a lot of people had bad experiences.” As Gia Grace had never 
been in a committed long-term relationship, she continued to feel comfortable using condoms 
and did not perceive a need for additional contraception. However, there have been a few 
instances where she has used emergency contraception following unprotected sexual intercourse.  
 Gia Grace accessed LNG-EC for the first time three years ago after realizing that a 
condom had ripped. Anxious and unwilling to accept the risk of an unintended pregnancy with 
someone who she did not want to raise a child with, Gia Grace immediately went to the 
pharmacy to purchase emergency contraception. She requested Plan B® from a young male 
pharmacist who asked if she had used it before and awkwardly provided her with a “brief 
overview” of the medication. Feeling slightly more relaxed, Gia Grace proceeded to the check-
out and returned home to take her emergency contraception. She worried that the side effects 
would be “even more elevated” due to her menstrual history, but fortunately, the cramping was 
tolerable. Despite the lack of tenacious side effects, Gia Grace’s mind raced for two weeks as she 
awaited menstruation: 
I’m like, what happens if this doesn’t work? (Chuckles) And just, uh, 
overthinking the scenario of what happens if it doesn’t work. And how 
do I tell my family, and how did I get myself in this position? I need to 
be more responsible. Just all those – these little things played out in my 
head. 
When her next menstrual cycle began a few days later than anticipated, all the tension that Gia 
Grace had been holding in her body finally relaxed. Overcome with joy, she and her partner were 
relieved that everything had worked out.  
 The following year, Gia Grace was in a relationship and asked her partner to ejaculate 





she could access emergency contraception again, Gia Grace had to reassure her partner, who 
quickly became “panicky” and “paranoid.” When she went to the pharmacy a few hours later to 
request Plan B®, the pharmacist delivered a quick “spiel” and gave her a generic brand. Gia 
Grace left feeling prepared and at ease, but her partner’s ongoing panic made her feel “more 
stressed about his reaction” than the possibility of becoming pregnant. Gia Grace carried a sense 
of guilt throughout this experience and wondered if she should pursue routine contraception, but 
she felt validated and unsurprised when her next menstrual cycle began. 
 Months later, Gia Grace visited an acquaintance’s home when she was intoxicated. As 
neither of them had a condom, Gia Grace was pressured into having unprotected sex and 
expressed immediate regret afterwards. She went to the pharmacy the next morning with a 
heightened sense of urgency and much to her surprise, the pharmacist informed her that Plan B® 
was no longer kept behind the counter. Despite feeling horrible about the incident, Gia Grace 
was pleased that emergency contraception was now treated like a “regular” over-the-counter 
medication that could be accessed without “discomfort or shame.” She placed Plan B® in her 
shopping basket and browsed for a few more items before checking out. Still upset, Gia Grace 
went home, read the instructions on the box, and took Plan B®. She did not experience any 
cramping this time, but her anxiety persisted and Gia Grace recalled “waiting down the days” 
until she was finally able to relax when she began menstruating.  
 Last year, Gia Grace was watching television and discovered that Plan B® may have 
reduced efficacy for women in larger bodies. Shocked to learn about the weight warning from a 
television series rather than from a health care provider, Gia Grace became angry and upset, as 





I instantly was like, wait what? (Chuckles) And I, like, Googled the hell 
out of it and then finding all this information, like, why did no one say 
anything? Thankfully, like, for whatever reason, it was fine for me those 
three times I used it, but […] I don’t feel like that was ever properly 
articulated to me, and at any time. 
Adding to her frustration, none of her friends knew about this warning and posts on online 
groups and forums revealed that other women’s experiences were “all over the place.” In 
hindsight, Gia Grace thought she may have been offended if the pharmacist had commented on 
her weight and stated that she should have read the package insert, but she still believed that it 
was the health care provider’s duty to fully inform patients about any medical risks. Following 
this experience, Gia Grace now thoroughly reads all her medication information prior to use. 
5.4 Ivy 
 Twenty-four-year-old Ivy is a white lesbian woman who described herself as an 
“awkward, Autistic person.” Unfortunately, Ivy has often felt judged, patronized, and dismissed 
by health care providers. Her long-time family doctor has also expressed confusion about her 
sexuality and was sometimes “rude” as a result, such as inquiring about her partner’s genitals. 
Following many negative health care experiences that have only worsened with age, Ivy has 
become distrustful of doctors and now limits her health care to transactional encounters. 
Nonetheless, Ivy used routine and emergency contraception throughout her adolescence, when 
she was “quite small,” and into adulthood, now as a woman in a larger body. In general, these 
experiences have left Ivy feeling over-monitored and under-informed by health care providers. 
 Growing up, Ivy attended a Catholic school where she received a poor-quality sex 
education. She was “pretty young” when she had unprotected sex for the first time, so an older 





by the lack of privacy, Ivy quietly accessed Plan B® from her neighbourhood pharmacy several 
times throughout her adolescence. The pharmacist always verified that she knew how to use 
emergency contraception, but Ivy did not fully understand its purpose at the time, as she 
admitted: “I wasn’t like .. 100% sure what it did. Like, was it like an abortion? Like, I had no 
idea.” She recalled being “pretty freaked out” during these experiences, but would hope for the 
best and move on. 
 Ivy began using routine contraception when she was 15-years-old. Without much 
discussion, her family doctor prescribed OCPs and simply directed Ivy to “take the pill.” She 
experienced constant nausea after initiating contraceptive use, but her doctor suggested that this 
disturbance was unrelated. Ivy was frequently given short-term OCP prescriptions, which forced 
her to return to her family doctor’s office every few months. This provision of care posed a 
barrier to consistent contraceptive use, as Ivy was sometimes unable or did not want to pick up 
her prescription renewal. In spite of the “horrible” side effects and inconvenient access, she 
continued to use her first brand of OCPs on-and-off for several years.  
 When Ivy began dating her current partner a few years ago, she had just relocated and 
was unable to access her contraception. Ivy and her partner sometimes used external condoms 
during this time, but there were two instances where she needed emergency contraception 
following unprotected sex. On each occasion, Ivy and her partner went to a pharmacy the next 
day to purchase Plan B®. Despite having insurance to help pay for the OCPs, cost had 
previously prevented Ivy from accessing emergency contraception so she was grateful when her 
partner offered to pay the second time. Although she felt remorseful and worried about becoming 
pregnant while living in a larger body, Ivy described both pharmacy encounters as merely 





attributed to the emergency contraception or her fear of pregnancy. Having learned from a friend 
that Plan B® may be less effective for women in larger bodies, Ivy experienced “gnawing” 
anxiety until her next menstrual cycle, as she thought: “Oh shit, maybe it didn’t work, maybe 
you waited too long, you know? Maybe what you heard about it not working for some people is 
true.” Conversely, in her most recent experience, Ivy had to prioritize other ongoing issues and 
soon “forgot” that she had taken Plan B® until she began menstruating. 
 When she later discontinued her first OCP, Ivy’s nausea improved and she realized that 
her contraception had indeed contributed to her symptoms. Ivy had a friend who used a different 
brand of OCPs, so she decided to see if this contraceptive would be a good fit for her. 
Considering her new location and the strained relationship with her family doctor, Ivy typically 
accessed health care from nearby walk-in clinics. She requested the new OCP at the end of an 
appointment, which “pissed off” the doctor due to the clinic’s one-issue-per-visit policy. Ivy 
panicked when the doctor stated that he usually did not prescribe contraception without a vaginal 
exam, as she would sooner forgo health care altogether. He finally agreed to write a prescription, 
but Ivy was surprised when the pharmacist told her that she had only been prescribed one 
package: a single month’s worth of contraception.  
 After experiencing nausea, emotional changes, bloating, and menstrual disruption with 
her new OCP, Ivy recalled thinking: “maybe birth control is just not good for me.” Ivy continued 
using her OCPs, albeit imperfectly, until she sought emergency care for what she thought was a 
“stomach bug” and learned that she was pregnant. Ivy decided to have an abortion, which was a 
difficult experience for her and her partner. Contraception was discussed twice throughout her 
abortion care, as she was first provided with brief information about various methods and later 





sometimes felt that health care providers were “condescending” as a result. While her 
contraceptive options and their respective risks were never thoroughly explained, Ivy appreciated 
that the doctor at the abortion clinic was “straight and informative.” Nonetheless, Ivy was 
unwilling to try a different contraceptive method because IUDs and all alternative options 
sounded “really scary.”  
 Ivy’s body now feels “better than normal” using her third brand of OCPs. Along with a 
regulated menstrual cycle, Ivy does not have any side effects and rarely experiences menstrual 
cramping. However, Ivy became increasingly frustrated that doctors only offered her short-term 
prescription renewals and felt patronized by a pharmacist who “didn’t seem convinced that [she] 
knew what [she] was doing.” Unsatisfied with her contraceptive care, Ivy decided to enrol in a 
virtual health care service. This platform enabled her to access contraception “in surplus” 
without interacting with health care providers, as she exclaimed: “they just send birth control [to] 
my door. And I don’t have to worry about it, it comes every three months, they give me three 
packs!” Even though Ivy now accesses and uses OCPs consistently, the threat of another 
unintended pregnancy persists in her thoughts. Adding to this concern, Ivy’s family doctor and 
peers have cautioned her against starting a family until she loses weight and she confessed: 
I’ve been told horrible things about – and I know that they’re not all true, 
rationally. Like I’ve – I’ve, you know, looked it up and I know rationally 
that it’s not all true. But I’ve heard terrible things, that you’re, like, a 
horrible mother if you get pregnant while you’re, like, obese and stuff. Or 
like, if you’re overweight that you have a really hard time, and, you 
know, it’s not good for your baby, and I’m like, “Oh shit!” and that’s, 
like, really scary to me. 
As she fears the emotional impact of another abortion and how her body size may threaten future 
family planning, Ivy continues to experience anxiety surrounding her contraceptive use and 






 Alice is a “nerdy” 23-year-old white woman whose journey with contraception began 
when she was 11-years-old. Alice experienced heavy, irregular menstrual periods that “made for 
some awkward conversations” when she was questioned about her frequent washroom visits and 
had to tell her teachers: “I don’t want blood all over your classroom.” In addition to profuse 
bleeding and cramping that felt like “a bowling ball trying to like break out of [her] skin,” Alice 
also experienced significant mood swings, headaches, and digestive issues that accompanied her 
menses. Consequently, her mother scheduled an appointment with their family doctor and 
requested a prescription for Alice to begin using OCPs. Suffering and terrified, Alice entered the 
realm of contraception from a place of desperation to regain control of her body. 
 Contraceptive use initially provided some relief, as the OCP “reduced the symptoms, but 
it didn’t get rid of them.” Alice used this contraceptive for several years until her menstrual cycle 
began to change and her symptoms became increasingly painful. Upon sharing her concerns with 
her family doctor, Alice was referred for a pelvic ultrasound and prescribed a different OCP. 
When the ultrasound did not detect any irregular pathology, her doctor “played the roulette” to 
find a contraceptive that would control her symptoms. In doing so, however, Alice often felt 
excluded from conversations about her own body. Throughout the next few years, Alice’s doctor 
cycled her through two more OCPs with little discussion or success, as she recalled: 
Um, typically what would happen is he’d say, “You’re going to try this 
one.” And then the discussion would be done, no matter what I wanted. 
[…] [T]here was no open for discussion, there was no “Okay, which one 
do you want to try? Um, here’s the side effects, here’s what you’re likely 
to experience based on the experiences we’ve had, the tests we’ve done 
with your body here.” None of that happened. None of it. It was just, 
“You’re going to try this. We’re going to see what happens. Have fun.” 





Besides the OCPs “not working,” Alice was distressed by her increasing body size. Having 
always been a “bigger girl,” Alice repeatedly requested a prescription that would not impact her 
weight, but was told that weight gain was inevitable. Given the scant dialogue surrounding her 
contraceptive care, Alice had to ask her pharmacist or browse the Internet for information about 
each new prescription. It was not until university that Alice saw another doctor and learned that 
she had a contraindication for all the OCPs that her family doctor prescribed (i.e., COCs). She 
then used a progestin-only OCP for a few years, albeit it did “nothing” to manage her symptoms.  
 Alice was adamant about using external condoms when she became sexually active. After 
spending the afternoon with a new casual partner a few years ago, Alice panicked when she 
realized that she had unprotected sex. Her partner lied about using contraception, as Alice 
declared: “He never took a condom off. He wasn’t wearing a fucking condom!” She tried to take 
her OCPs at the same time every day, but knew that she had missed a pill earlier that week. In 
tears and unsure what to do, Alice phoned her mother, who tried to comfort her and suggested 
that she seek emergency contraception and STI screening. After calling to confirm that Plan B® 
was available, Alice drove to the pharmacy with a friend. When she requested Plan B®, the 
pharmacist responded, “Which one of you is it for?” and asked for her weight. He proceeded to 
tell Alice that she could purchase Plan B® if she wished, but warned that LNG-EC was “pretty 
much not effective at all” for women who weighed over 165 pounds. Alice became “a mess of 
emotions,” as she not only felt embarrassed that “lots of people” overheard their conversation, 
but also explained: 
I was really scared because now my failsafe’s gone. I’m angry ‘cause, 
like, I didn’t choose my weight at that point, like I – I’d been fighting it 
and fighting it, but like, I was still gaining weight. Um, and like, at my 
height 165 [pounds] would be – it’d be very, very, very, very thin. Um, 





I’m fat or because I’m tall?” Like, which – which one? Like, and 
honestly, I felt a little jealous of women that were smaller. I mean, why is 
everything built for them, why not – why is there nothing that I can use to 
protect myself? Because it’s not just smaller girls that face things like 
this. We do too, but there’s no – no Plan B for us, I guess. 
The pharmacist did not present any alternative options, so Alice purchased Plan B® “just in 
case.” She left “feeling lesser because of the size of [her] body” and returned home to take the 
emergency contraception, call her mother, and cry herself to sleep. 
 Alice did not experience side effects upon using Plan B®, which made her believe that it 
was not working. Consequently, she felt afraid, tense, and anticipated the need to take a 
pregnancy test. However, she no longer cared about menstruation when her human 
immunodeficiency virus (HIV) test results were inconclusive and she was sent for repeat testing. 
Having felt like a helpless, anxiety-ridden, “rundown version” of herself throughout the entire 
experience, as it was “almost like the world didn’t care what happened to [her],” Alice was 
relieved when her second HIV test came back negative a few months later.  
 Throughout the next year, Alice’s menstrual pain worsened significantly and she became 
desperate for a new method of contraception. Her family doctor finally offered her a choice: 
Alice could try another OCP or she could be referred to a gynaecologist for an IUD consultation. 
Her doctor also noted that she had basically “gone through all [the OCPs],” so Alice sensed that 
she did not really have a choice between the two and opted for the IUD.  
 Alice was “terrified” when she arrived at the gynaecologist’s office, but was soon put at 
ease by the “comfortable” waiting room and “genuinely nice” staff. After discussing the options 
with the gynaecologist, Alice felt confident in her decision to select an LNG-IUD and have it 





prescription at the pharmacy, Alice returned to the office and was calmed by her gynaecologist’s 
helpful explanation of the insertion process. She experienced discomfort during and following 
the procedure, but the cramping was far less painful than her regular menstrual symptoms.  
 Despite some weight gain and initial uncertainty about how her body would react, Alice 
now describes her LNG-IUD as a “Godsend.” Her menses are still “highly irregular” and “very, 
very, very painful,” but Alice is grateful that she is no longer “incapacitated” by her symptoms 
and needs not worry about a daily regimen or emergency contraception. Nonetheless, she 
continues to feel frustrated that she cannot control her body size and wishes for better access to 
highly-effective emergency contraception for women in larger bodies. Under the care of her 
gynaecologist and a new family doctor who helped to diagnose her with PCOS, Alice now feels 
genuinely supported in her contraceptive care.  
5.6 Summary 
 The five participant stories presented in this chapter provide a glimpse of the 
considerably diverse contraceptive experiences captured in this study. The social identities and 
personal contexts that formed the basis of participants’ lived experiences often became 
interwoven into their accompanying contraceptive journeys. Moreover, health care providers 
evidently played a crucial role in women in larger bodies’ experiences, as participants described 
how health care encounters shaped the ways they engaged with and felt about their contraceptive 
care and use. Throughout the next three chapters, I will attempt to delineate some of the 
similarities and divergences in women in larger bodies’ lived experiences with contraception by 
presenting broad themes that hold significant meaning for various participants, while using 
subthemes to highlight nuanced experiences. Chapters 6 and 7 are dedicated to routine 





Chapter 6: Embodied Contraceptive Use 
 To understand how contraceptive use becomes embodied by women in larger bodies, this 
chapter will examine participants’ lived experiences with routine contraception. Participants 
reported using female-oriented routine contraception for the first time when they were between 
11 and 23 years of age, with the majority initiating use before the age of 20 years. There was 
variation in how women in larger bodies came to use contraception, with some participants 
requesting it themselves and others being directed by their health care providers or parents. 
Many participants were originally prescribed contraception for non-contraceptive purposes, 
including menstrual management or acne control, and several women initiated contraceptive use 
for pregnancy prevention. Some women tried routine contraception for a limited period of time 
before deciding to discontinue use, but many participants were long-term users. 
 Women in larger bodies’ experiences with routine contraceptive use varied greatly, 
ranging from “horrible” to “amazing,” with many experiences falling somewhere in between. 
The overarching theme of control was common across all women’s lived experiences, with 
participants sharing a common understanding of contraception as a means to prevent pregnancy 
and regulate menstruation. Some participants also viewed contraception as a source of security, 
freedom, or empowerment that gave them control over their bodies and their lives. The extent to 
which control was emphasized and whether it was achieved depended on the context surrounding 
the use of contraception. Given the complexity and diversity of participant experiences, I will 
explore women in larger bodies’ journeys with routine contraceptive use and control. 
Participants’ experiences were highly personal and the meanings they assigned to their 
contraceptive use sometimes changed over time, and therefore, the findings are not meant to 





meaning in a fluid and evolving relationship. In this chapter, I present five themes: (1) Feeling 
Out of Control; (2) Negotiating Control; (3) Feeling Empowered; (4) Experiencing 
(In)Convenience; and finally, (5) Feeling “Normal.”  
6.1 Feeling Out of Control  
 As previously mentioned, women in larger bodies used contraception to gain a sense of 
control, whether that be for menstrual regulation, family planning, or otherwise. Throughout the 
interviews, however, several participants described largely negative experiences with 
contraception and their bodies more broadly. Consequently, participants found themselves in a 
state of disarray where they felt out of control surrounding their contraceptive use. 
6.1.1 Menstruation Run Amok 
 Many women’s experiences with contraception were shaped by their menstrual cycles 
and symptoms. Numerous participants indicated that they had “painful” or “irregular” menses 
characterized by cramping, unpredictable bleeding, or heavy flow, often manifesting as a 
combination thereof. For some participants, this pain was debilitating. The notion of “erratic” 
menstruation was exemplified by Antara, who was prescribed OCPs for PCOS management 
when she was a teenager. Describing her menses and early experiences with contraception, 
Antara shared: 
I used to have really bad cramps, to the point where I had to call in sick 
to work. Um, yeah, and then, at times I also would have fever and uh, 
like, it wasn’t a pleasant thing for me. Like, having my periods was [a] 
very bad experience, I’m kind of happy I don’t get it [now]. But at the 
same time, kind of worried as well. […] First pill, yes, the cramps did 
improve, my periods, um, were heavy, um, and I used to get really sick as 
well. I would throw up, very dizzy, the feeling of weakness, um, and 
fever. Like I would, you know, you could get the fever from exhaustion. 





or my body would be really warm. Um, headaches. Just – just a very 
discomforting feeling. 
Although Antara’s cramps improved, some of her “discomforting” menstrual symptoms 
nonetheless persisted with her first OCP. Thus, while several women used contraception to help 
manage their menstrual cycles, participants sometimes experienced partial or no relief. 
 Unfortunately, some participants were perpetually unable to control their menstrual 
irregularities. A few women described an arduous journey as they tried to find a method of 
contraception that would alleviate their affliction with their bodies. For instance, Sloane’s mother 
encouraged her to seek OCPs for acne treatment when she was 15-years-old, but Sloane also 
experienced “really, really awful periods” that could not be regulated, let alone contained, by 
contraception. Sloane had “full periods” if she missed a single pill and continued to experience 
breakthrough bleeding even after switching to a different OCP. She briefly tried other methods 
but felt too anxious using the vaginal ring, which also caused discomfort during sex, and her 
LNG-IUD spontaneously expelled from her uterus within the first 12 hours of its insertion. 
Sloane ultimately returned to OCP use until her symptoms became unbearable and she insisted: 
“I can’t live with these periods and this pain anymore!” With the help of medical imaging, 
Sloane has since been diagnosed with adenomyosis and endometriosis. Her symptoms are now 
being managed with a non-contraceptive hormonal medication, albeit the pain quickly returns if 
she misses a few doses. Overall, Sloane’s unrestrainable menstrual cycle and symptoms were 
central to her experiences with contraception and will likely continue to impact her reproductive 





6.1.2 Feeling at Odds with the Body 
 Many women felt that contraception was sometimes, if not always, at odds with their 
bodies. Participants experienced side effects that were disruptive to their physical and mental 
health, often resulting in method dissatisfaction and discontinuation. Participants described a 
myriad of symptoms that they attributed to their contraception, including but not limited to 
depression, anxiety, weight gain, menstrual disruption, migraines or headaches, acne, pain, 
nausea, and decreased libido. In this way, the opportunity to gain control of their bodies came at 
a cost. While some women were able to manage or minimize these disturbances, others were left 
feeling out of control due to the tenacity or severity of their side effects. 
 Some participants noted physical changes that negatively impacted their wellbeing. This 
concern was expressed by Alice, whose story was introduced in Chapter 5. Alice noticed that she 
gained weight with each contraceptive she used, an effect that persisted “regardless of what [she 
did] to mitigate it.” Reflecting on what it meant to face this side effect time and time again, Alice 
declared:  
I don’t want to be any bigger than I already am. I am already fighting 
with my body to get it back down to [a] healthy weight […] having to 
fight my birth control to be able to do that is very frustrating. And it kind 
of makes me feel, when I put on a lot of weight because [of] my birth 
control, that in order to protect myself, I have to be less aesthetically 
pleasing in society and I have to kind of hide my body more and I don’t 
like that. I really fucking hate it, honestly. 
Frustrated and painfully aware that contraception was constantly at odds with her body, Alice 
felt that she did not have any options that would not give her “an even bigger body.” Weight gain 
had a deteriorative effect on her body image, as Alice felt that she had to “hide” her body from 





as she knew that when her IUD is removed and she transitions to her next contraceptive, she will 
still be unable to prevent her weight from increasing. 
 Some women experienced new or elevated mental health effects that left them feeling 
distressed about using contraception. Participants who disclosed anxiety or mood disorders 
tended to feel more profoundly impacted by changes in their mental health. For instance, Sultana 
suggested that OCPs “nullified” the effect of her antidepressants. Sultana was prescribed OCPs 
for pregnancy prevention when she was in university, but discontinued use after feeling that 
contraception did “more harm than good.” In addition to gaining a significant amount of weight, 
Sultana professed that she was greatly concerned about her rapidly declining mental health:  
[I]t impacted my, like, depression as well – like very severely. Like, I had 
to, like, drop out of the semester, um, because I was just, like, not feeling 
anything. I was, like, very numb. I was not going to school, um, I was 
not, like, taking care of all the things that I should. So um, after that, like, 
I just decided that, like, it was not something that I wanted to, like, 
pursue. It – like, I was like, “Okay, you know what, if I’m, like, having 
sex with my partner, I would rather just, like, stick to condoms,” at that 
point in time. 
Contraception impacted Sultana’s depression so intensely that she was unable to complete her 
coursework, and she later admitted feeling suicidal during that time. While she recognized the 
preventative benefits of using OCPs, she believed that they were acting directly counter to her 
antidepressants and hence, her overall wellbeing. One decade later, Sultana was offered OCPs to 
manage her newly diagnosed PCOS; however, given her history, she firmly stated that she would 
only accept an LNG-IUD. Sultana’s IUD was recently inserted and her body was on a “heavy 
bleeding cycle” at the time of the interview, but she was glad that she had not experienced any 
“severe” mental health effects. Together, Alice and Sultana’s experiences exemplified the 





 Finally, three participants suggested that their bodies had rejected contraception. Upon 
using a new contraceptive, these participants experienced acute physical effects that they 
interpreted as their bodies’ noncompliance with contraception. For instance, Barbara repeatedly 
stated that her body “did not like” contraception. After briefly using OCPs during her 
adolescence, Barbara initiated use again when she was 20-years-old, but quickly became worried 
that she had developed blood clots. She recalled: 
I never had a problem before and then my legs would start hurting in the 
middle of night, I would get cramps, my heart would race. I, you know, I 
used to get headaches – I never had headaches before. You know, I 
thought it was like blood pressure, they tested me, they said my blood 
pressure was high – I never had blood pressure problems before. So, at 
that point I assumed, “Okay, it’s the pill.” 
Emphasizing the personal novelty of these symptoms, she concluded that her body had rejected 
the OCPs and later stated: “you shouldn’t feel horrible taking medicine that you know is going to 
help you.” As a result, Barbara discontinued her contraception and decided that it would be 
“safer” to use external condoms exclusively. 
 In comparison, Quinn and Sloane struggled for years in search of a method of 
contraception that worked well for their bodies. Quinn continued to experience extreme OCP 
side effects and, as previously noted, Sloane was unable to control her menses and anxiety. Both 
participants hoped that LARC would provide a solution to their respective issues, but their 
optimism was curtailed by the displacement or expulsion of their IUDs. Quinn tried the Cu-IUD 
on two occasions, only to be met with pain and disappointment each time. They explained:  
Um, both times I had my IUDs inserted were inc – extremely traumatic 
[…] like, my body was just so not willing to cooperate. Like, they had a 
hard time getting it in, I remember bleeding a lot. Um, I felt terrible, I 
thought – I honestly just remember feeling like a trapped animal on the 





like bottom part of the T on your little, your IUD. And so, I went to [the 
hospital] and I got a nurse practitioner and she did a very rough manual 
exam on me as she said, “Well, I can’t feel it, it’s fine.” And I said, “No, 
I know it’s there, I know it’s out of place, it’s not [fine].” [She replied,] 
“No, no, it’s fine.” And then sure enough, a couple of days after that, I 
was having cramping and pain and I was – like I could feel the base of 
the IUD, just the opening of my cervix, and I went back [to the hospital] 
and I was like, “Somebody needs to take this out of me because I am very 
uncomfortable.” 
Quinn felt that their body was “not willing to cooperate” with contraception and had earlier 
stated that both IUDs “came out in no time on their own.” As such, Quinn believed that their 
body was at odds with intrauterine contraception, which led to their uterus rejecting it 
completely. However, this perception was not limited to Cu-IUDs. Following these experiences, 
Quinn used a vaginal ring for four days, but established that they were “super allergic” to it upon 
experiencing significant pain and tissue damage. After trying “pretty much everything available” 
without success, Quinn eventually concluded that their body “rejected everything, essentially.” 
The perception of contraceptive rejection was upsetting to participants, as the failure to find a 
suitable method of contraception may have, in a way, signified the unruliness of their bodies. 
6.1.3 Distrust, Defeat, and Damage 
 Some participants did not fully trust their contraception because they did not believe they 
could truly achieve control through its use. A few participants described how the vaginal ring 
invoked concern about imperfect placement or timing of use. In contrast, when Barbara used 
OCPs for pregnancy prevention, she admitted: “I still used condoms because […] I don’t believe 
in a pill being a wonder worker, you know – you know, that can do everything. I don’t believe 
that at all.” Barbara wished that there were more contraceptives “catered towards larger bodies,” 
as her options were limited to “invasive” IUDs and untrustworthy OCPs, which compelled her to 





 Coupled with distrust, a few participants felt defeated following their dissatisfactory 
experiences with contraception. Both sentiments were expressed by Quinn, who finally obtained 
a tubal ligation after a long and “complicated” journey with routine contraceptive use. Reflecting 
on their time using reversible methods of contraception, Quinn confessed:  
I wanted to trust in the contraceptives I was using. I really wanted to have 
found a solution that would help me to really confidently have sex and 
not be terrified the entire time that it was going to be making a baby or 
having, you know, causing a pregnancy. So yeah, like, I would say, like, 
yeah, there was just a lot of tension in my body before [the tubal 
ligation], because I didn’t completely trust my – my contraceptive. It’s 
like sitting on, like, I don’t know, a swing in a school playground where 
you’re like, “I am an adult and in an adult body. I don’t know about this 
swing; I’m just going to sit on it and see what happens.” And that’s kind 
of what contraceptives felt like to me, where it was like, “Uuugh! They 
told me it would be fine, but we’ll see.”  
Through the swing analogy, Quinn not only expressed a distrust in contraception to uphold its 
purpose, but also a distrust in their own body to respond well to contraception. What is more, 
Quinn knew that LNG-EC may be less effective for their body weight, which left them feeling 
frightened and stuck between “a rock and a hard place constantly,” as Quinn woefully 
proclaimed: “there was nothing available to me to keep me from getting pregnant […] it was like 
abstinence or abortion. And there was nothing in between for me because I was fat.” As this 
quote suggests, participants who struggled to manage their symptoms or side effects sometimes 
expressed pessimism or resentment towards their contraception or their bodies. In Kendra’s case, 
OCPs contributed to her anxiety rather than alleviating her menstrual cramping. Although she 
continued to use contraception for a few years because she was “naïve” and unaware of other 
options, Kendra recalled thinking: “maybe there’s no solution to it, like this is just my body; this 
is the pain.” By centring themselves and their bodies, Quinn and Kendra also alluded to their 





 Finally, two women who were no longer using contraception implied that they had been 
damaged by lingering side effects. While the impact of the anxiety that Kendra associated with 
her experience with contraception was “still with” her seven years later, Antara experienced new, 
heightened, and improved side effects after concluding a nearly 16-year-long journey with OCPs. 
Antara had experienced a range of side effects throughout her use of contraception, but noticed 
significant changes in her wellbeing when she discontinued OCPs two years ago. At first, Antara 
endured a very difficult transition period, as she explained: 
[T]here was weight gain, but there was also really, like, for the first few 
months, my headaches were really, really frequent. Like, every other day 
I had a headache. […] And that also, like, I was very moody. It caused 
extreme mood swings, like, I would realize that this is a mood swing, I 
know this was happening. Um, depression, um, sudden out – like – like 
emotional outburst. Like, you know, when you get upset and, uh (sighs), 
you just become emotional at everything. Like, you start crying for no 
reason and stuff like that. So, the first few months were really difficult 
after I got off the birth control pill. 
By describing her mood changes as “sudden” and having “no reason,” Antara suggested that her 
emotions were out of control. Moreover, she later noted that she had previously experienced 
episodes of low moods; however, she felt that the “striking difference” was that she was 
diagnosed with anxiety and depression after discontinuing contraception. Overall, these physical 
and mental health symptoms made Antara “regret” her long-term contraceptive use, as she 
believed that “the damage [was] done” and her body needed to “recuperate.”   
6.2 Negotiating Control 
 Common across many participants’ journeys with routine contraception was the process 
and experience of negotiating control through the use, and sometimes subsequent adjusted use, 





tolerated certain side effects or inconveniences in consideration of their sexual and reproductive 
health needs. For instance, several participants noted that they disliked or struggled with user-
dependent contraceptive regimens, such as the daily use of OCPs. When women felt that they 
could not achieve adequate control with their method of contraception, they tended to adjust their 
contraceptive use to regain a sense of control. 
6.2.1 Prioritizing Needs 
 Women often negotiated control by considering what they could and could not tolerate, 
thus prioritizing their needs. By weighing the benefits with the costs, participants rationalized 
their ensuing decision to continue using contraception. For instance, using contraception 
properly and consistently became a “dire” need after Roxanne and Ivy both experienced an 
unintended pregnancy while misusing their OCPs. Roxanne had been using contraception to 
manage her heavy menstrual periods since she was 13-years-old, but her priorities sharply shifted 
towards pregnancy prevention following her abortion. After switching to the contraceptive 
injection for greater reliability, Roxanne began inquiring about sterilization in her early twenties. 
Her requests were largely unsuccessful until recently, and as a result, she subsequently used 
several methods of contraception, including vaginal rings, OCPs, and an LNG-IUD. Roxanne 
was never keen on hormonal contraception and struggled with user-dependent regimens; 
however, she feared another abortion and hence continued to prioritize pregnancy prevention 
through routine contraceptive use. Likewise, Ivy had a history of unpleasant side effects and 
inconsistent access to contraception, but she maintained OCP use following her abortion. 
Although both women are currently content with their respective contraceptive methods, 





suggests that women may continue to negotiate control over their bodies while prioritizing their 
needs.  
 Other women discussed prioritizing their needs with respect to menstrual management. 
For instance, following years of on-and-off use due to long-standing concerns about weight gain, 
Beyoncé began using contraception consistently after she was diagnosed with PCOS and her 
symptoms eventually became too much of an “irritant.” Additionally, several participants 
negotiated control by tolerating menstrual disruption while their bodies adjusted to a new 
contraceptive. While Sapphire considered herself an IUD advocate, she did not initially like her 
intrauterine contraception, as she explained:  
At the beginning with the IUD, it was about three to six months before I 
decided I liked it. It was very um .. like, lots of cramps and stuff at first, 
but they – they told you that, like she said, “It’s gonna be weird for a few 
months, and maybe unpleasant, but then it’ll be good. Trust me.” So I 
just stuck it out and she was right. Um, so yeah, it was really, um, 
unpredictable periods and spotting and stuff and cramps, and for the first 
few months, and then it levelled out.  
By “st[i]ck[ing] it out,” Sapphire prioritized her long-term needs over her initial menstrual 
disturbances and was eventually able to benefit from her new contraceptive. This sentiment was 
reported by some of the other IUD users who described enduring uncomfortable or agonizing 
insertions and menstrual side effects before ultimately feeling satisfied, as Roxanne recalled, “the 
actual [IUD insertion] process was one of the most painful experiences I’ve had in my life.”  
 In a few other instances, participants were prompted to prioritize their needs when side 
effects or disturbances developed over time. This negotiation of control was demonstrated by 
Steph, whose OCPs managed her endometriosis symptoms for many years. She recently began 





believe that “the pill is not as effective” anymore. Steph is now less satisfied with her 
contraception; however, she also experiences medical anxiety and internalized weight stigma 
from years of what she described as feeling “brushed off” or stigmatized during health care. 
Considering that her menstrual health is still “significantly” better with contraceptive use, she 
has not addressed her concerns. While this decision suggests that Steph prioritizes the menstrual 
benefits that she is afforded through OCP use, it also emphasizes how weight stigma has 
impacted her experiences with contraception, as she admitted: “if I didn’t have [medical anxiety], 
I would definitely be on a different pill right now or even a different form of contraceptive.”  
6.2.2 Perceiving (In)Stability  
 Some women negotiated control to gain stability that they believed had been lost to 
method-related inconveniences or side effects associated with the use of contraception. A few 
participants attempted to endure side effects before ultimately seeking a new contraceptive to 
correct their embodied sense of disarray. For instance, when Luna began using OCPs for acne 
treatment when she was 19-years-old, she wanted to ensure that her contraception would be 
minimally disruptive to her mental health and ongoing intentional weight loss. While her needs 
were met, Luna also began to experience breakthrough bleeding, as she described: 
I would have my period for like two weeks, but it was, like, it wasn’t [a] 
full-blown period. Um, it’s like I would have two weeks where I would 
have absolutely no breakthrough bleeding or anything, and then for two 
weeks I would have, like, very light spotting, but enough that I didn’t 
want to wear my underwear. Um, so it was enough that I felt like I 
needed to wear a pad, and wearing a pad for two weeks just really is 
uncomfortable and inconvenient. 
Given her discomfort, Luna eventually wanted to correct her menstrual cycle disruption. 





switch to a third and final OCP that stifled her breakthrough bleeding. Although she now 
believes that these menstrual changes may have been associated with her weight loss, Luna 
valued the acne treatment that contraception provided and thus negotiated control over her body 
by trying new prescriptions in search of an OCP that curbed her side effects to stabilize her 
menstrual cycle.  
 For other women, gaining stability was more complex. When Beyoncé began using 
contraception for pregnancy prevention at 18 years of age, she believed that she would have “the 
most control” with OCPs. Yet, she struggled with the daily regimen and eventually switched to 
the vaginal ring for greater convenience. As previously described, Beyoncé also tried to gain 
stability by using contraception on an on-and-off basis to manage the weight gain she 
experienced with both methods. Stating, “it’s almost like my chest deflates!” when she 
temporarily discontinued her contraception, Beyoncé explained that her weight was “a personal 
concern, more than a health concern per se.” To complicate matters further, Beyoncé’s PCOS 
meant that when she stopped using contraception to stabilize her weight, her menses were 
irregular. Regardless of her need for consistent contraceptive use for menstrual regulation and 
pregnancy prevention, Beyoncé negotiated this control for several years to maintain some 
stability in her body size.  
6.3 Feeling Empowered 
 Several women described feeling empowered by contraception, as it liberated them to 
take control of their bodies and their lives. Some participants were content with their first method 
of contraception, while other women navigated the use of various contraceptives before finding 
one that adequately met their needs. As such, empowerment was not necessarily a destination, 





6.3.1 The “Better” Body  
 After finding a good fit, numerous women explained how contraception ultimately 
improved their relationships with their bodies. Feeling “better” while using contraception was 
often associated with symptom control and minimal unwanted side effects. For instance, the last 
chapter featured Tuck’s experience using contraception for PCOS management. Tuck felt 
“lucky” that her body responded “really, really well” to OCPs and thought that contraception had 
“done exactly what it’s supposed to do,” including the regulation of her hirsutism and menstrual 
cycle. Similarly, women were pleased with the non-contraceptive benefits that their 
contraception provided. Although Sapphire did not begin using contraception to manage her 
menstrual periods, menstrual regulation became central to her experiences, as she declared:  
I have horrible, horrible periods. Just awful. And [contraceptives] really 
help. With the IUD actually, I haven’t had an actual period in, like, a 
couple years now […] which I love (chuckles). Like once in a while, like, 
maybe like every six months or something, I’ll have, like, a little bit of 
cramping as though I’m going to [get my period], but not nearly as bad, 
but then I don’t have it. […] And when I was on the pill, it – I still got 
my periods, but they were much more regulated and very short, and um, 
really, really helped with cramps and stuff. So, I like being on it all the 
time. Whether or not I’m having sex or not. 
While many participants were negatively affected by bothersome side effects at one point or 
another, Sapphire’s experience demonstrated the positive impact that contraception had on some 
women’s bodies. 
6.3.2 Feeling Confident 
 Contraception empowered some women to feel confident in themselves and their 
relationships. When participants had trust in their use of contraception, it faded into the 





sometimes discussed with respect to non-user dependent methods of contraception, which freed 
women from worrying about correct or perfect use. Some participants noted how these 
contraceptives provided them with “peace of mind.” For instance, Lilieae began using 
contraception for pregnancy prevention when she was 16-years-old and selected the 
contraceptive injection for its high efficacy, “get it and forget about it” regimen, and ability to 
suppress her menstrual periods. Lilieae happily received the injections for many years, but 
recently had an LNG-IUD inserted after experiencing hair loss that may have been attributed to 
her contraception. Undeterred by the contraceptive injection’s possible side effect and the initial 
pain from her IUD insertion, Lilieae was very content with both methods overall. Reflecting on 
her experiences using contraception, she gushed: 
I feel great, honestly […] I don’t really have, like, mood swings and I just 
feel more like myself. I haven’t really – yeah, I’ve had no other side 
effects so, like, I feel great. Like, the peace of mind is fantastic, the fact 
that I don’t have to worry about menstruating is amazing – like, super 
happy about it.  
Contraception empowered Lilieae to feel confident in her body and her ability to prevent 
pregnancy. By indicating that she was able to “feel more like [her]self,” Lilieae additionally 
suggested that contraception not only enhanced her health, but her embodied sense of self and 
personal life as well.   
 The multifaceted benefits of contraceptive use were further illustrated by Mavis, who was 
introduced in Chapter 5. Mavis began using contraception to prevent pregnancy, but also 
explained that contraception had improved other aspects of her life:  
I think that contraception’s really been a great factor in our relationship. 
You know, I’ve been able to talk openly with my partner about when we 
plan on going off of contraception. And I’m lucky to have a partner 





really supportive of, eventually, my decision to be off of birth control. 
So, I think that it’s – it’s just really allowed me to, um, you know, be in a 
very healthy relationship.  
While most participants discussed contraceptive use as a highly intrapersonal phenomena, 
Mavis’ experience demonstrated how it also helped her to feel confident in the “very healthy 
relationship” that she fostered with her partner, who played an active and supportive role in 
family planning discussions.  
6.4 Experiencing (In)Convenience 
 While many participants had complex or polarizing experiences, two women suggested 
that contraception was merely an (in)convenience that held little significance or meaning in their 
lives. Gwen began using OCPs to suppress her menses during a summer job when she was 16-
years-old. As she enjoyed avoiding the “ugh! Grossness of, like, having a human body,” Gwen 
continued using her contraception. She is still taking OCPs now at 26 years of age, but she is not 
sexually active and has “never really paid any attention” to her contraceptive use beyond noting 
some occasional menstrual spotting. Thus, although Gwen has momentarily considered re-
evaluating her long-term contraceptive use, she will likely continue to take a laissez-faire 
approach as long as she benefits from the convenience that OCPs afford her through menstrual 
suppression. 
 Alternatively, contraception represented more of an inconvenience for Gia Grace, whose 
story was highlighted in the previous chapter. In consideration of her unchanged menstrual 
symptoms and “hectic” personal schedule, Gia Grace decided to discontinue OCPs, as she 
explained: “it didn’t feel, like, necessary to go through the struggle of going to the pharmacy, 





learn that Gia Grace did not try a different method of contraception; however, by referring to 
accessing and using OCPs as a “struggle,” she implied that using contraception was 
inconvenient. Parallel to this sentiment, Gia Grace recently decided against initiating 
contraceptive use, as she confessed: 
I was just overwhelmed with the decisions and trying to find the best 
route, and didn’t want to be, like, trying one avenue and it didn’t work, 
and then try something new. Because I’ve done that for other things and 
it’s just so frustrating when something doesn’t work out, then you have to 
try multiple other sources and, like, ways to do it to get what you want. 
And in the end, if condoms are working for me, why would I go through 
that headache? 
Evidently, Gia Grace anticipated that it would be challenging to find a satisfactory method of 
contraception. By referring to the process of selecting and using contraception as a “headache,” 
Gia Grace suggested that she valued the convenience of external condoms over any labour (e.g., 
emotional, physical, financial, or otherwise) that she may need to endure to use female-oriented 
methods.  
6.5 Feeling “Normal” 
 Lastly, participants who used contraception on a long-term basis often explained how, for 
better or for worse, contraception became part of their lives. Women in larger bodies 
consequently described a sense of normalcy surrounding their experiences with routine 
contraceptive use. 
6.5.1 Normalizing Use 
 Regardless of the method or how “perfectly” it was used, the act of using contraception 
was often normalized by long-term users. As such, while they may not have had control over 





through the integration and subsequent routinization of contraceptive use into their everyday 
lives. For instance, though it took time for Luna to find an OCP that did not disrupt her menstrual 
cycle, using contraception was always “minimally invasive and annoying,” as it became part of 
her nightly routine with the help of an alarm. Likewise, Antara used OCPs for nearly half of her 
life and explained: “I was on it for so long, it was like, it was normal, it was like having food. 
[…] [I]f you’re hungry, you eat it. Like this is, like, a pill you take every day.” Comparing her 
OCPs to eating food, Antara suggested that using contraception became instinctive. This attitude 
was echoed by Gwen, who took multiple medications each day. Emphasizing the mundanity of 
using contraception, she shared: 
I feel like I’ve been on it for so long and it’s for something that’s so, like, 
like, low impact in my life. Like, it’s just like, “I just don’t have a 
period” that it’s just – it feels so normal. Like, I have a lot of other 
medical conditions. […] I take lots of different pills, every day 
(chuckles). Um, and so it’s just, like, it’s part of life – you know, I take 
three pills in the morning, two pills at dinner and then one pill before bed, 
and it’s just kind of, like, part of life. 
Gwen had been using her OCPs for the last decade of her life, and hence contraception had 
become an integral, albeit unremarkable, part of her daily routine.  
6.5.2 The “Normal” Body 
 In addition to normalizing the act of using contraception, several participants described 
how their bodies also felt “normal” at some point throughout their experiences with 
contraception. Some women began to feel a newfound sense of normalcy when they believed 
that their bodies had adapted to the hormonal influx that accompanied contraceptive use. For 
instance, after successfully managing her symptoms for a few years, Tuck hoped that 





discontinued her OCPs for one month. Much to her disappointment, Tuck’s hirsutism became 
“noticeably” worse during this time, which induced feelings of bodily disarray that prompted her 
to return to contraceptive use. Thus, while most participants reported missing an OCP dose from 
time to time, some women felt that the bodily changes they observed during longer lapses in use 
confirmed that the perceived bodily control and corresponding sense of normalcy they had 
become accustomed to were dependent on contraception. 
 While many participants could clearly articulate how their bodies responded to 
contraception, as seen throughout this chapter, some women also expressed ambiguity. A few 
participants noted that they were not particularly in-tune with their bodies, as Roxanne asserted: 
“my body and I, we don’t really speak the same language.” Nonetheless, long-term users 
sometimes became so acclimated to contraceptive use that its effects seemed to have become 
partially intertwined with their natural bodies – meaning that these participants could not 
distinguish whether certain changes they experienced were caused by contraception or otherwise. 
For instance, some women discussed uncertainty with respect to changes in their weight, 
emotionality, or mental health. Lilieae explained that her weight had “ballooned” in her 15 years 
of contraceptive use and identified weight gain as a known side effect of hormonal 
contraception, yet she believed that several other circumstances could have also contributed to 
the observed changes in her body size. Moreover, as some participants’ contraceptive use 
spanned a large portion of their lives, a few women could not imagine their bodies without it. 
When reflecting upon how her body felt when using contraception, Steph mused:  
I feel like, because I’ve been on it for so long, I’ve been on it for like, 
almost half my life. I honestly can’t remember what it was like to feel in 
my body not being on it. So, I personally don’t – and like I – because I 
started to take it, like, right when I hit puberty, I don’t know what it’s like 





Emphasizing that she could not recall her body being any other way, Steph’s experience 
suggested that in some ways, long-term users may have come to understand contraception as part 
of their regular living bodies. In each of these examples, participants acknowledged their 
uncertainty but did not seem to investigate any further, thus demonstrating the minimal 
disturbance or low personal significance of this ambiguity, as their bodies truly just felt “normal” 
when using contraception. 
6.6 Summary 
 When asked what contraception meant to them, most women discussed bodily control in 
terms of prevention and regulation. However, by highlighting different dynamics in women in 
larger bodies’ embodied experiences with routine contraceptive use and control, this chapter 
revealed that the meanings that participants assigned to their lived experiences were usually 
more complex. While contraceptive use often became normalized over time, women’s sensations 
of control over their bodies varied within and across participants, ranging from embodied 
feelings of unruliness to empowerment. Some participants had strong impressions of control or 
disarray, whereas others negotiated control over their bodies throughout their lived experiences 
with contraceptive use. For a few women, contraception was merely an (in)convenience that held 
little significance in their lives. Given that many participants were long-term users who had used 
more than one contraceptive, the findings demonstrated the dynamic nature of women in larger 








Chapter 7: Routine Contraceptive Care 
 Grounded in the context of embodied contraceptive use, in this chapter, I examine 
women in larger bodies’ experiences navigating routine contraceptive care. Participants 
described their experiences accessing female-oriented contraception and receiving care in a 
variety of health care settings, such as independent or group practices, walk-in clinics, university 
health centres, hospitals, sexual health clinics, and pharmacies. In doing so, participants 
interacted with both prescribing and dispensing health care providers, including family doctors, 
nurse practitioners, gynaecologists, endocrinologists, and pharmacists. While several participants 
believed that contraceptive care was relatively simple to access, some felt that it involved more 
discomfort, screening (e.g., questions, Pap test), and surveillance than other health care.  
 Much like the previous chapter, my analysis revealed significant diversity in women’s 
experiences accessing and using contraceptive care, with many participants describing both 
positive and negative interactions with health care providers. Consequently, I found that women 
in larger bodies’ experiences with contraceptive care were shaped by feelings of 
(dis)empowerment. In this chapter, I present four predominant themes of meaning: (1) 
Experiencing Stigma; (2) Feeling Dismissed; (3) Taking Control; and (4) Feeling Supported. 
7.1 Experiencing Stigma 
 Common across many participants’ lived experiences was an overarching sense of 
stigma. Though most women did not explicitly refer to stigma, many participants described 
instances where they felt judged, embarrassed, or otherwise uncomfortable, which I interpreted 
as experiencing stigma. Participants sometimes experienced stigma in intersecting and 





felt stigmatized by their health care providers or peers, whereas others succumbed to their own 
internalized stigma. To introduce this theme, I describe some contextual considerations that help 
situate women in larger bodies’ experiences with stigma throughout their contraceptive care. 
 In general, many participants thought that contraception, or sexual and reproductive 
health more broadly, was uncomfortable to discuss. Some participants acknowledged, as 
Roxanne said, the “innately sexual” nature of contraception and, supposedly, its surrounding 
conversations. This sense of discomfort was distinct from other health-related topics, as some 
women noted that it was a cultural or social taboo to talk about menstruation, contraception, 
sexual activity, or female anatomy. For instance, Sloane explained that she was raised in a “small 
town and a very conservative religious family,” and as a result, she was not exposed to 
conversations about sexual health until she attended university. Similarly, discomfort with sexual 
and reproductive health was sometimes attributed to a lack of comprehensive sex education.  
 Although the interviews focused on contraception, weight was discussed by nearly all 
participants. Some women stated that their weight had never come up during contraceptive care, 
whereas others shared relevant experiences or pondered whether perceptions of their bodies had 
shaped the contraceptive care they received. For instance, certain participants believed that living 
in a larger body added a layer of complexity to accessing contraception. Mavis noticed “a tie 
between a larger body size and high blood pressure when it comes to prescribing contraception,” 
as her blood pressure was monitored more closely than her smaller-bodied friends, including 
those who were hypertensive. Despite making a “conscious effort” to relax before her 
appointments, Mavis experienced some anxiety about her blood pressure and occasionally 
wondered if she would be refused contraception if her reading was too high. Weight-related 





suggested that they may have received different contraceptive care had they been living in 
smaller bodies. For instance, Barbara was briefly prescribed OCPs when she first began 
menstruating at age 14 years because her doctors incorrectly assumed that she would have PCOS 
based on her body size. While she reflected more positively on her recent contraceptive care, in 
general, Barbara believed that medical education reinforced a “prejudice” towards individuals in 
larger bodies and expressed that some doctors seemed to look at her like she was “the 
disgustingest person in the world.” In this way, while the notion of weight stigma was sometimes 
relevant to contraceptive care, it was more frequently discussed in the broader context of women 
in larger bodies’ health care experiences.   
 Several women noted that weight was at the forefront of most of their other health care 
encounters, and many participants recounted at least one experience where they believed that 
their care was impeded by health care providers’ attitudes towards their bodies. Negative health 
care encounters ranged from observing “very subtle microaggressions” to more clear instances of 
weight bias, stigma, and, unfortunately, discrimination. To illustrate, Quinn explained:  
As a fat person, the amount of fatphobia and gaslighting and, like, 
emotional abuse that I have encountered just trying to get basic care for 
things outside of reproductive health have made me avoidant of doctors. 
Um, I’m very, very, very skeptical of new health professionals. […] Um, 
you don’t tend to have a trust for doctors when, again like, the only thing 
they ever wanted me to have when I was a kid was diabetes. And then 
that same doctor who diagnosed me with hypoactive thyroid also told me 
to my face, as an eight-year-old, that I was morbidly obese and told my 
Mom to stop sending me to school with lunch. Um, I have a real fear and 
distrust of doctors, so all of these years – I’m only now starting to really 
take care of my thyroid health because I’m doing it for me and I have a 
nurse practitioner who doesn’t – who doesn’t let fatphobia tinge her 
practice. 
Such statements demonstrated the ways in which negative attitudes towards larger bodies 





care system. Thus, weight stigma played a pervasive role throughout numerous women in larger 
bodies’ overarching lived experiences.  
 Lastly, it is important to acknowledge that several women in larger bodies faced 
compounding stigmatization due to their intersecting identities. Additional discomfort was 
sometimes reported by participants who perceived an ethnic, cultural, or religious stigma, and 
those who described stigmatizing health care or contraceptive care experiences related to their 
sexuality, non-monogamy, mental health, or neurodivergence. Overall, experiencing stigma 
contributed to feelings of disempowerment among women in larger bodies. 
7.1.1 Internalizing Stigma 
 Shaping the foundation upon which women in larger bodies’ experiences with 
contraceptive care were built, previously established negative attitudes and stigma impacted how 
participants engaged with health care. Internalized stigma was commonly discussed with respect 
to women in larger bodies’ stigmatizing experiences within the broader health care system, 
which subsequently influenced how they approached their contraceptive care. For instance, 
various participants shared how they exercised precaution when seeking new health care 
providers; experienced anxiety, discomfort, distrust, or exhaustion during medical appointments; 
or actively avoided health care unless necessary. Gwen, who had not spoken with a doctor about 
her contraceptive use since she was prescribed OCPs 10 years ago, admitted: “my absolute terror 
of doctors, which I think is largely caused by, like, being a fat person, has a really big impact on 
the way in which I interact with contraception.” Even though Gwen used contraception for the 
convenience of menstrual suppression and was grateful that her experiences had been “smooth 
and unintrusive,” she expressed some ambivalence by acknowledging that she should perhaps be 





I don’t know many fat people who like going to doctors, because it’s just 
not the best experience most of the time. I hate getting weighed, I don’t 
weigh myself except when they make me do it at the doctor’s [office]. I 
don’t like [it] – so for me, it’s just always really, like, an anxiety-
inducing, stress-inducing kind of thing. Which is, again, one of the 
reasons why I’m not like, “hmm I should sit down and talk to them about 
my contraceptive options!” Like, obviously I should, but like, I’m 
terrified of doctors, and I’m fine!  
Given that she attributed her fear of doctors to her identity as a fat person, Gwen suggested that 
internalized weight stigma has, in part, contributed to her medical anxiety. Moreover, she also 
stated that she attended mandatory appointments for her other health conditions, but would never 
“voluntarily go talk to a doctor unless [she was] deeply unwell,” including contraceptive care. 
This attitude was affirmed by a handful of other participants who, at one point or another, 
avoided contraceptive care due to the impact of their other health care experiences.  
 In addition to weight stigma, participants also described internalized feelings of stigma 
related to stereotypes or social norms surrounding their contraceptive use. As previously noted, 
some participants were uncomfortable discussing sexual and reproductive health in general, 
whereas others felt that contraceptive care was particularly vexing because it revealed their 
engagement in sexual activity. Given their internalized discomfort, some participants refrained 
from sharing certain personal information, asking questions, or raising their concerns during 
contraceptive care. Kendra became sexually active when she was already using contraception for 
menstrual cramps, yet she was “shy” about telling her family doctor that the OCPs were also 
serving as “protection.” Stating that she did not feel comfortable discussing “anything sexual” 
with her doctor at the time, Kendra pointed out:  
I didn’t really want to talk to this 60-year-old man about, kind of, Tinder 
[dating application] and whatnot, and casual dating and one-night stands 





was I think also that thing of like, this was the doctor that I had my entire 
life. So it just kind of felt like – it’s like talking to my Dad about it. 
While Kendra expressed discomfort with regards to discussing her sex life with an older man, 
she also revealed the non-monogamous nature of her sexual relationships at the time. She later 
emphasized the importance of finding a doctor who was “open and non-judgemental” about 
casual dating, and hence it is possible that Kendra felt embarrassed or feared that she would be 
judged for her non-traditional sexual activity. Likewise, Sloane admitted that she used to be 
reluctant and ashamed to tell her doctors when she was having sex with multiple partners. 
 Women’s personal sense of stigma sometimes further resulted in avoidant behaviours or 
self-concealment when accessing their contraception. Tuck had long “jump[ed] through hoops” 
to bypass her family doctor when renewing her OCP prescription due to her internalized stigma 
and in reflection, she remarked: “I’d say the majority of my life, accessing health care has felt, 
like, uncomfortable because I’m fat and uncomfortable because I’m uncomfortable with talking 
about sex and reproductive health.” In comparison, Beyoncé frequently took pregnancy tests 
prior to initiating OCP use, so she often experienced “guilt and shame” when accessing 
contraceptive care. Although she did not necessarily recall any negative health care encounters 
with regards to her contraceptive use, she explained: “I’ve always kind of felt like there’s 
judgment because of my – my sexual activity or, um, what kind of led me to – to need or want 
contraception.” Propelled by her internalized stigma, this shame was not confined within the 
walls of her family doctor’s office. Beyoncé further explained that she masked her prescription 
when accessing contraception from the pharmacy: 
Beyoncé: I don’t know why but I guess there’s still a little bit of 
embarrassment. And I can’t really pinpoint the reason for that. Um, and 
also, there’s a little bit of secrecy around the fact that I’m going to get 





Interviewer: And what do you mean by, like, secrecy? 
Beyoncé: Like I’ll make sure I get a bag to put the prescription in – or 
the uh, the – yeah, like, the medication and so it’s not obvious what it is. 
By concealing her prescription from the public eye, Beyoncé also hid her engagement in sexual 
activity and the embarrassment that she felt, thus avoiding any judgement that she may have 
anticipated. Somewhat parallel to this behaviour, Barbara accessed contraception from an 
“anonymous” clinic where she opted to pay for her OCPs out-of-pocket to avoid exposing her 
contraceptive use by using her father’s insurance. Overall, internalized stigma prevented 
participants from fully and openly participating in their contraceptive care, which sometimes 
impacted the quantity and quality of care they received. 
7.1.2 Perceiving Stigma 
 Several participants perceived stigmatizing behaviour from health care providers during 
their contraceptive care. Some women observed non-verbal cues, such as judgemental tone, 
staring, or agitated body language. For example, Roxanne was very perceptive to her health care 
providers’ behaviour. In 26 years of contraceptive use, Roxanne interacted with many different 
health care providers, none of whom seemed particularly comfortable discussing her sexual 
health. Roxanne noticed that doctors rarely met her eyes when she initiated conversations about 
contraception, which resulted in “incredibly awkward” contraceptive care. She explained: 
I’m generally pretty uncomfortable. I mean, you know, you take body 
language cues and stuff. If I say to a doctor, you know, “Oh and I have 
to, I have to talk about birth control,” then they kinda – and they kind of, 
like, they get – like they shift their position in the chair and everything 
and they get all uncomfortable and stuff and it’s like, “Oh, okay.” So, if 
the doctor is uncomfortable speaking about these things, then like, I, you 
know, I tend to be pretty blunt, and just kind of lay it out there 
(chuckles). But if the doctor is feeling uncomfortable then I’m like, 
“Ooh” – I try to be careful about what I say. I don’t always – I don’t 





Because it’s like we just – both of us kind of want the conversation to be 
over. 
Admittedly, Roxanne became more reserved when she sensed that doctors were uncomfortable 
discussing her contraceptive care. By taking note of their fidgeting, Roxanne mirrored this 
uneasy body language in her own communication, as she asserted: “it’s hard to have a level of 
trust when the person won’t even look you in the eye.” Although she generally “la[id] it out 
there,” the stigma that Roxanne perceived hampered her ability to openly discuss her sexual and 
reproductive health. This barrier, in turn, negatively impacted the quality of care she received, as 
she may have avoided raising all her contraceptive-related concerns to avert further discomfort.  
 Alternatively, some women described stigmatizing questions or comments made by 
health care providers during their contraceptive care. The nature of such remarks included, but 
were not limited to, perceptions about participants’ bodies, sexual activity, or agency. For 
example, weight was often discussed with respect to gynaecological conditions, such as PCOS, 
concerns about weight gain, and contraceptive efficacy. A few participants understood why these 
conversations were initiated and believed that their doctors did so in a sensitive manner, whereas 
others viewed comments about their bodies to be irritating and uncalled for. Steph’s first family 
doctor focused on menstrual symptom management during her contraceptive counselling; 
however, she also warned Steph that her menstrual periods “may be worse” because of her 
weight. As a young girl recently diagnosed with endometriosis and newly menstruating at the 
time, this comment made Steph feel particularly insecure, as she explained: 
I was 14, like, that’s such a – like a young and vulnerable age […] when I 
went to that appointment, like, I had just gotten my period like a few 
months before, like, it’s something really new. I find, like, girls are like 
pretty self-conscious when they – when they first get their period. So it 





discuss my weight] because I felt, like, so self-conscious after […] like, it 
wasn’t the worst, like, most negative experience, but it definitely could 
have been better. Like, I felt like it wasn’t very encouraging. 
By weaponizing her weight, Steph was made to feel even worse about her body than she already 
did when she sought care for her irregular menses. Thus, in addition to the internalized stigma 
that some participants had established prior to accessing contraceptive care, Roxanne and 
Steph’s experiences demonstrated how participants’ perceptions of stigma during contraceptive 
care could become internalized as well, which further disempowered women. 
  Beyond inducing feelings of discomfort, verbal stigma sometimes led to contraceptive 
care avoidance. The impact of stigma was poignant for Antara and Sultana, who both perceived 
an ethnic or cultural stigma from health care providers with similar South Asian backgrounds. 
When they were each in their early twenties, a pharmacist told Antara not to have sex “just 
because” she was using contraception and Sultana felt pressured by health care providers who 
projected their religious values during her care. Reflecting on her first experience with 
contraceptive care, Sultana shared: 
Um, it was very condescending, the doctor whom I had, um – and maybe 
it’s like also, like, a part of the cultural background too. So like, um, lots 
of people at least don’t talk about [contraception] in, like, the South 
Asian community, but because like, lots of people are severely, like, 
religious or like, have like, very like, um, cultural – like blind spots. Um, 
so one of the things is that, like, at least my experience with some of the 
doctors in the [city], was that, like, the first question they will ask [is] 
like, “Are you married?” And I was like that’s – that’s, like, not okay for 
you to ask me, like, I’m asking you about like my contraceptive options, 
so. And then they will ask like, “Why do you need it?” So that – that was 
my other thing that, like, I should not have to answer, but like, that – that 
was my very bizarre experiences with some of the doctors .. the first time 
around. 





stigmatized by the doctors’ intrusive questions. In light of their experiences, Antara escaped 
further scrutiny by waiting until the pharmacist was not working or asking her sister to pick up 
her prescription, and Sultana avoided contraceptive use until she found a more respectful doctor. 
 Lastly, one woman described a stigmatizing contraceptive care experience that had a 
distinctively negative impact on her mental health and wellbeing. When Sloane was 19-years-
old, she was referred to an “aggressive” older male gynaecologist for an LNG-IUD. She phoned 
the gynaecologist upon realizing that her IUD had been expelled merely hours after its insertion 
and was advised to return to the office for an examination. After sitting in the waiting room for 
more than three hours the next day, Sloane was finally taken in for her appointment and recalled: 
I showed [the IUD] to him and he was like, “I don’t know what’s wrong, 
there’s something wrong with you, you must be infertile, there’s 
something wrong with your uterus,” blah blah blah. And like, I’m crying 
and anxious, and – I can’t control that my body expelled the IUD, like, I 
don’t know what happened. And I just felt really shamed and 
uncomfortable. So after, I was – I just shut down, it wasn’t good. 
Not only was Sloane blamed for her spontaneous IUD expulsion, but she was also told that she 
“must” be infertile. This experience exemplified some of the hostility that women in larger 
bodies described facing both within and beyond contraceptive care. 
7.2 Feeling Dismissed 
 Many participants reported situations where they felt dismissed by health care providers, 
leading to perceptions of suboptimal contraceptive care and unmet care needs. Women’s 
perceptions of dismissal stemmed from a variety of experiences that ranged from feeling hurried 
to having their reproductive autonomy denied. This finding was specific to experiences with 






7.2.1 Heard…But Not Always Listened To 
 Many participants described one or more instances where health care providers did not 
listen to their expressed contraceptive needs or concerns. While some women believed that “the 
doctor knows what’s best,” participants became frustrated when they felt their voices were being 
undermined or neglected. Participants commonly described feeling dismissed when inquiring 
about certain contraceptive methods, expressing concerns about side effects, and articulating 
their lived experiences with contraceptive use.  
 The extent to which women in larger bodies were not listened to varied. Some 
participants sensed that they were not trusted or believed by their health care providers, whereas 
others felt utterly ignored. Sapphire, for example, recounted an “annoying” contraceptive care 
discussion that she had with her previous family doctor. When Sapphire explained that she was 
experiencing decreased libido and noted that it was a common side effect of her OCPs, her 
doctor simply responded: “no, that shouldn’t be happening.” He obliged when she eventually 
requested to try a different brand, but Sapphire concluded that their interaction “sucked.” In 
comparison, some participants described how health care providers attempted to persuade them 
to use a method of contraception that did not reflect their stated needs, disinterest, or previous 
experiences with harsh side effects. For instance, after undergoing a tubal ligation following 
several failed attempts to find a contraceptive that worked for their body, Quinn was still 
encouraged to use contraception for PCOS management. When their gynaecologist 
recommended OCPs, Quinn objected and gave a “whole spiel” explaining their experiences with 
contraception. Despite emphasizing how “bad” they always felt while using OCPs, Quinn’s 





I told her, I was like, “Listen, this is going to do bad things to me and I 
really don’t want to do it.” (Sighs) And this is, like, an OBGYN 
[gynaecologist] who I’ve observed a lot of fatphobic behaviour from, so I 
wasn’t surprised that she didn’t listen to me. […] I know my body but, 
you know, who cares? 
By minimizing their complicated history with contraception and OCP side effects, Quinn’s 
gynaecologist invalidated their lived experiences, which may have, in part, reflected fatphobic 
attitudes. As they later described feeling “tired and exasperated” following these conversations, 
Quinn’s experience demonstrated how they were disempowered by interactions with health care 
providers who refused to consider, let alone acknowledge, their embodied expertise.  
 Unfortunately, this encounter was not the first time that Quinn’s voice was disregarded 
during contraceptive care. Participants who expressed interest in permanent contraception were 
frequently met with disapproval from health care providers, which ranged from “subtly shutting 
it down” to “almost being chastised” for making such a request. All three participants who 
requested surgical interventions recalled being told that they were either “too young,” they “may 
change their minds,” or that “nobody would sign off on it.” Such responses were frustrating and 
sometimes hurtful to hear, as participants oftentimes felt that discussions about permanent 
contraception were unproductive or disrespectful of their autonomy. Lilieae recently began 
initiating conversations with her family health team about having a hysterectomy in the future, 
but noted: 
I don’t know that they’re necessarily taking my point of view into 
consideration. Again, we’ve not really had in-depth conversations about 
it as of yet – I was just kind of, very early .. feeling out the waters with it, 
sort of thing. Um, but even with that early on, I feel like the conversation 
very definitely could have been like, “Let’s talk about it, like, this should 
be an option. Let’s see whether or not it’s the best option or if there’s a 





Although Lilieae generally felt well-supported throughout her contraceptive care and understood 
why her health care providers had reservations about referring her for a hysterectomy, she was 
frustrated that they were unwilling to have an open discussion about this option. Parallel to 
disagreements about permanent contraception, Sultana recalled leaving a contraceptive care 
appointment empty-handed after the doctor told her that she was “too young to decide that, like, 
if [she] really wanted an IUD.” These experiences further demonstrated how some participants 
felt as though their voices were disregarded from conversations surrounding their own bodies. 
 Finally, some participants felt discouraged and defeated when health care providers failed 
to support their contraceptive needs. These sentiments were embodied by Luna, whose family 
doctor often made her feel like her health concerns were unimportant. Luna was dismissed when 
she inquired about the breakthrough bleeding that she experienced with her first OCP, so she 
“put up with it” and avoided contacting her doctor for “a really long time,” as she confessed: “I 
felt so anxious about, um, being too annoying or even putting undue strain on my doctor when 
there might be people out there who have worse problems.” Luna internalized her doctor’s 
dismissive behaviour and began to believe that her irregular bleeding, albeit “incredibly 
inconvenient,” did not warrant his time. In a similar manner, Alice “gave up” after repeatedly 
making unsuccessful requests for contraception that would not induce weight gain and 
exclaimed: “it made me feel like I wasn’t being listened to, like, I didn’t – my concerns weren’t 
valid. […] [T]he best way I can describe it, is I felt like I was talking to a brick wall about my 
health.” By comparing her doctor to a brick wall, Alice suggested that her attempts to address 





7.2.2 Rushed Out and Uninformed 
 Although some participants acknowledged that their health care providers were 
understandably busy, many women described instances where they felt rushed and insufficiently 
informed when receiving contraceptive care. Several participants expressed unmet informational 
needs, as they asserted that they had limited contraceptive options presented, little explanation 
provided, or few opportunities for discussion. Some women noted that when they were younger, 
they did not have enough interest or understanding to probe further and truly participate in their 
contraceptive care. While participants who initiated contraceptive use at a young age typically 
received brief or paternalistic care during adolescence, this trend sometimes carried into 
adulthood. This authoritarianism was reported by Roxanne, who frequently sensed that she was 
“pushed through” her contraceptive care appointments and believed that the options were never 
“fully explained.”  
 Participants who were presented with limited options sometimes described a take-it-or-
leave-it attitude from health care providers, which in turn made women feel like they did not 
truly have a choice in their contraceptive care. For example, various participants recalled 
appointments where they were only offered OCPs, with a few women even admitting that they 
were unaware of any other options at the time. Kendra received brief, “cold” care from her 
family doctor when she sought help to manage her menstrual cramps in her early twenties. After 
sharing her symptoms, Kendra was promptly offered OCPs, upon which she reflected: 
I found that there was no kind of alternative options that were presented 
to me. Like, you know, learning, obviously more now [about] like, IUDs 
and all those other options, those were never presented to me. And it was 
kind of just like, “This is the one that I recommend. Either you’re on it or 
you’re off,” and I kind of just the, you know, again, like, the band-aid 
solution of – and I guess maybe it’s also, you know, the way my doctor 





your 15 minutes. If you’re having issues, let’s talk [about] them, but 
that’s [it], like, you know, your 15 minutes are up. Next patient.” 
Kendra’s experience demonstrated how some participants felt obligated to accept their health 
care providers’ recommendations when they did not have the opportunity to discuss a variety of 
options and make an informed decision. Moreover, by referring to contraception as a “band-aid 
solution,” Kendra suggested that while her concerns were readily addressed, her care was not 
thorough. This sentiment was echoed by a few other women who believed that hormonal 
contraception was prescribed to provide a quick fix in lieu of further investigating their 
menstrual concerns and hence, the hormones were merely masking their symptoms. 
 The depth of the counselling reported by participants who described rushed or brief 
contraceptive care varied. Some participants were sent off with no more than a brand name and a 
prescription, whereas other women were offered basic information about their options or the 
contraceptive method they were prescribed. Numerous participants additionally recalled 
instances when they received biased, incomplete, or inadequately explained information – 
particularly with respect to risks and side effects, as Ivy stated: “there are things that I feel like I 
should have been told that I was not told.” Regrettably, women sometimes felt that they did not 
have enough time or were too uncomfortable to ask questions during their appointments.  
 Participants bridged the information gap by speaking with pharmacists, reading 
pamphlets or the package inserts, and engaging in “self-directed” learning. Throughout their 
experiences, several women discussed contraception with their friends and many sought 
information from various online sources, including sexual health organizations, forums, social 
media, blogs, videos, scientific articles, websites like WebMD, and even product monographs. 





they also emphasized the importance of finding credible sources that offered objective 
information.  
 Some women searched for information to learn more about a newly prescribed 
contraceptive, whilst other participants wished to proactively prepare for their appointments. 
Beyoncé sensed that she was expected to educate herself and reported fleeting discussions where 
she only received “general” contraceptive information, such as regimen explanations, from her 
family doctor. Despite doing online research and preparing questions to ask during her 
appointments, Beyoncé sometimes still felt inadequately informed. Considering her internalized 
sense of stigma and her doctor’s brief, impersonal care, Beyoncé reflected:  
I would have loved to have my doctor, like, ask if I had any questions or 
if I understood everything or if I needed more information, uh, to make it 
more comfortable or easier for me, too. […] Ask those questions if I have 
them now, so that I wouldn’t have to go home and, like, Google stuff 
afterwards (chuckles). 
This sentiment was echoed by several participants who expressed a desire for open contraceptive 
discussions involving more options, information, resources, or personalized recommendations. 
Interestingly, some participants also placed the onus of education on themselves, stating that they 
should have been more informed or asked more questions during their contraceptive care.  
7.3 Taking Control 
 While participants usually initiated contraceptive discussions with their health care 
providers, the last theme demonstrated that women were not always in control of the care they 
received. As a result, some participants felt compelled to take contraceptive care into their own 
hands. Control was sometimes sought when women sensed that their care had not been 





using the contraceptive injection, but had to urge her family doctor to compare her results. 
Although her scans were always within normal limits, Lilieae wanted to know if the comparisons 
revealed “small incremental changes” due to the risk of bone density loss associated with the 
injections, but it seemed like her doctor “didn’t seem to really, per se, care about it.” Similarly, 
other participants also emphasized the importance of self-advocacy during contraceptive care.  
 Some women described instances where they asserted themselves in response to 
dismissive or authoritarian health care providers. As previously noted, the notion of bodily 
autonomy was particularly important in the context of LARC or permanent contraception. Luna 
was interested in using OCPs or the contraceptive implant, but felt that her family doctor was 
“narrowing down the choices” by strongly recommending an LNG-IUD. Describing how she 
approached this conversation, Luna shared:  
I felt like I kind of had to convince him in a certain way to take the IUD 
off the table and consider the implant and the pill. And I also, uh, wanted 
to make sure to tell him that, like, these are the things that I think would 
help me, based on, like, my courses and my sex education. These are the 
things that I think will solve my problem. But ultimately, you kind of are 
powerless in the end because you present all of the information and then 
the doctor is sort of like the judge that makes that final decision.  
By referring to the doctor as “the judge,” this metaphor positioned Luna as a defendant on trial 
who had to plead her case to be awarded autonomy over her body. Interestingly, a few 
participants implied that disrespectful or paternalistic care might have been attributed to their 
gender or body size, as Quinn frequently discussed the relentless self-advocacy that they did in 
the face of fatphobia and “classic everyday misogyny” when seeking a tubal ligation. This 
sentiment was echoed by Sultana, whose doctors often tried to “push” her towards OCPs or 





I don’t know if it’s just like, women don’t get taken seriously when 
they’re talking about their health, or if you are a person with a bigger 
body that you’re not taken seriously when you’re talking about your 
health. But like, doctors have like, so much, like, agency in terms of, like, 
how they want to proceed and what they want to proceed – you literally 
have to, like, fight for it. […] [Y]ou have to like really, really like 
advocate for yourself, and like very, like, vehemently say no, like that’s 
not something you want, or otherwise they will just, like, bulldoze you 
and not hear you at all. 
Given that she later stated that it had been an “uphill battle” to finally access an IUD, Sultana’s 
experiences revealed an imbalanced patient-provider power dynamic wherein she had to “fight” 
for her contraceptive care. Together, these examples demonstrated how participants used varying 
approaches to seek control over their bodily autonomy. 
 In addition to gatekeeping specific contraceptive options, some participants reported 
instances where health care providers restricted their access to contraception. This provider 
barrier was experienced by Sapphire, who requested an LNG-IUD after her current family doctor 
made OCP access “far too difficult” by requiring in-office prescription renewals every three 
months. Along with Sapphire, a few participants described taking control of their contraceptive 
care when they believed their bodies were being policed. Of notable importance, Gwen was the 
only participant to express opposing opinions. Gwen “loved” that she had always been able to 
renew her OCP prescription over the phone, but given her medical anxiety, she proposed that she 
may benefit from mandatory appointments to “make [her] stop and think about it.” In this way, 
Gwen would first need her family doctor to take an authoritarian stance to prompt her to truly 





7.4 Feeling Supported 
 Many participants felt supported at some point throughout their experiences with routine 
contraceptive care, albeit “support” had different meanings to various individuals. At the least, 
women were grateful to access contraception, with some participants acknowledging both their 
own privileges and the challenges that other women may face in comparison. Feeling supported 
was also closely related to having a comfortable relationship with prescribing providers, and 
women frequently reported receiving better care from young and/or female health care providers. 
Nonetheless, some participants favoured a hands-off approach to their contraceptive care and a 
few women felt supported despite receiving minimal information from their doctors. For 
example, Lilieae emphasized that she personally did not need much contraceptive counselling:  
Given my level of knowledge and the level of research that I was doing 
beforehand, I was happy with the care that I was given and I didn’t feel 
that anything was overlooked. But again, I knew about stuff so I didn’t 
need to ask them for the information, versus like, I feel like there 
probably should have been information that they had volunteered and 
discussed without me having to bring it up sort of thing, and that other 
women could have benefitted from. 
Lilieae later proposed that her doctor may have “tailor[ed] those discussions” to her knowledge, 
thus exhibiting a form of personalized care. Likewise, by explaining how they were or would 
like to be supported, participants described a preference for patient-centred approaches to 
contraceptive care.  
7.4.1 Collaborative Care 
 Participants felt supported when health care providers engaged in collaborative 
contraceptive care. Some women were grateful when health care providers were receptive to 





included in the decision-making process. For instance, after years of dissatisfaction with the 
contraceptive care she received from her family doctor, Alice reflected positively on her 
experience selecting an LNG-IUD when she was referred to a gynaecologist: 
So, we set up an appointment with the gynaecologist in town, and she 
went through – she was really good about saying like, “Okay, so what are 
your symptoms? How are the[y]? Okay, these are the two options. Here’s 
what I recommend, but if you don’t want that level of, like, hormones in 
you, because it is a stronger one and it lasts for longer, we can do another 
one. Like, let’s talk through the options,” which was fantastic, and I think 
also part of why I like my IUD so much is because, I actually – I didn’t 
get to choose it, but I chose it, if that makes sense. I felt like I was 
actually consulted. 
Although Alice felt that she did not truly choose to use an IUD because her family doctor 
presented no real alternatives, as highlighted in Chapter 5, she was content that her gynaecologist 
empowered her to select the brand that would best fit her needs. This sense of control over 
decision-making was of great importance to participants, particularly among those who had 
previously felt excluded or invalidated during their contraceptive care. 
 Several women also desired or appreciated open, holistic discussions about contraception. 
Prior to making a method selection, some participants spoke with their health care providers and 
discussed a variety of factors, such as the options they were interested in or comfortable using, 
possible side effects, cost, current symptoms, and past experiences with contraception. Quinn 
described having positive experiences with health care providers who listened to their lived 
experiences, respected their knowledge, and “tried really hard to find solutions.” After 
experiencing intolerable side effects when using OCPs, Quinn went to a sexual health clinic and 
spoke with a nurse practitioner about LARC. Recounting this conversation, Quinn shared: 
I have so much of this base information [about contraception, so] she 





she asked me some questions to make sure that it would work best for 
me. Because I told her about my history of cramping and she wanted to 
kind of steer me in the direction of Mirena [LNG-IUD] because the 
copper IUDs can cause, uh, more cramping. And I said, “Well, not 100% 
comfortable with Mirena,” because again it’s super expensive and it still 
has [a] hormone in it, even though it’s localized, I just don’t want to risk 
anything in my body that’s gonna make my mental health garbage. Um, 
so we kind of talked about it and she – we decided on the copper IUD 
kind of together. 
This experience involved an engaging conversation between Quinn and the nurse practitioner, 
where they selected a contraceptive method “together” in consideration of Quinn’s needs and 
lived experiences. Similarly, other participants noted that they felt supported when they believed 
that their doctors genuinely cared about them. Gia Grace emphasized that her current family 
doctor was “informative,” “attentive,” and never made her feel “rushed or pushed aside” during 
contraceptive discussions; a stark contrast from the care she received from her previous family 
doctor years prior. Moreover, following her endometriosis and adenomyosis diagnosis, Sloane 
was referred to an “incredible” gynaecologist in her home town. Sloane characterized their 
conversations about contraception and reproductive health as “very back and forth,” and 
explained: “she asks me questions and wants my input, whereas I found with other doctors, they 
just talk[ed] at me or told me things.” The distinction that Sloane had previously been spoken at 
rather than with is important, as participants felt respected and cared for when health care 
providers were engaging and demonstrated that they truly valued their patient’s perspective.  
7.4.2 Information-Rich Care 
 Women appreciated health care providers who offered detailed information to empower 
them to make informed decisions and feel confident in their contraceptive use. Participants felt 
informed when they learned about different contraceptive options and received information 





such as pamphlets or websites, that they could refer to should they desire more information. 
Mavis learned “a lot” about contraception from her doctors and enjoyed her first experience with 
contraceptive care, as she recalled: 
[My doctor] was really great at explaining each aspect of birth control 
and letting me know that changes are gonna happen in my body, but if 
changes don’t happen in my body, it’s fine. And sort of talking me 
through the transition of it. 
Given that this doctor worked in a “university town” and knew that Mavis was a first-time 
contraceptive user, she offered a wealth of information and provided Mavis with “the best care.” 
In other instances, some participants sought targeted information about specific methods of 
contraception to support or confirm their choices. For example, after expressing interest in 
having an IUD inserted, Sapphire felt confident in her decision to purse an LNG-IUD, as she 
explained:  
I had spoken to my – my family doctor first about it, and um, she gave 
me a lot of information. And so, I was able to go and make the decision 
myself [to have an LNG-IUD inserted] and then also speak to the 
gynaecologist [to get more information] before it happened as well. And I 
feel like those two steps were good for anyone making that kind of 
change to their body because it is invasive and painful. So, it was good 
having those two steps that really forced you to think about it and decide 
what you want to do and be made well aware of um, the side effects and 
everything. 
As the insertion was “invasive and painful,” having information in advance helped Sapphire 
make an informed decision and prepare for what was to come. This sentiment was echoed by 
other participants who valued personalized information and emphasized the importance of 
understanding all potential benefits, risks, and side effects associated with contraception.  
 Some participants felt well-informed throughout their contraceptive care, whereas others 





counselling. For instance, Antara received “barely any counselling” when she was initially 
prescribed OCPs by her family doctor, but felt supported by her endocrinologist, who gave her a 
“proper education” several years later. Nonetheless, a few participants did not receive detailed 
information from their prescribing providers, but rather reported that their pharmacists were, as 
Luna stated: “excellent in making me feel informed about what I’m taking.” Thus, while women 
were not always well-informed by health care providers at the time of decision-making, some 
participants were still able to obtain supplemental information from other trained professionals 
throughout their experiences with contraception.  
7.4.3 Non-Judgemental Care 
 Women in larger bodies reflected positively on their contraceptive care when they did not 
feel judged. Numerous participants desired or shared their experiences with health care providers 
who strived to reduce stigma through the practice of inclusive care. Open-minded, non-
judgemental contraceptive care was sometimes discussed with regards to creating a safe space to 
have conversations about sexual and reproductive health. For instance, some participants stated 
that they valued health care providers who did not make heteronormative assumptions or make 
them feel ashamed of their sexual activity. The concept of non-judgemental care also pertained 
to treating women in larger bodies with equity and respect. Barbara believed that weight was an 
inevitable topic in contraceptive care but explained that her perceptions of these discussions 
depended on the tone of the conversation:  
[Weight] is something they have to talk about anyways, because some of 
the, you know, contraceptions, it is by weight class and […] it’s the way 
they say it. If they say it’s by weight class, you know it’s not – it’s not 
rude like, “You’re too fat for this.” It’s something you know, it’s 





As such, weight-related discussions were not always perceived as stigmatizing. Barbara further 
indicated that she valued doctors who did not automatically problematize her weight, but instead 
treated her as a “human being first” – a positive health care provider trait that was also identified 
by some of the other participants. Steph, for example, felt supported by her current family 
doctor, who “reduce[d] the stigma about being, like, a larger person” using contraception and 
reinforced the notion that she deserved “good health care, too.” However, as previously 
described, Steph continued to avoid contraceptive care as much as possible due to the impact of 
her past health care experiences. Nonetheless, a few participants’ feelings about contraceptive 
care improved when they began to overcome the internalized stigma concerning their bodies or 
sexual health, which Steph strived to work towards with the help of her doctor. 
7.5 Summary 
 To summarize, women in larger bodies’ experiences with routine contraceptive care were 
shaped by feelings of (dis)empowerment. My analysis highlighted four major themes of 
meaning, revealing that while participants valued patient-centred approaches, women in larger 
bodies also described experiences where they received inadequate contraceptive information, 
care, and longed for more meaningful discussions with their health care providers. Overall, while 
several participants felt stigmatized or dismissed at some point throughout their experiences, 
some participants also described instances where they took control of their contraceptive care, 







Chapter 8: Emergency Contraception 
 In Chapter 2, I suggested that accessing and using emergency contraception may differ 
from routine contraception due to the distinct contexts in which they are used. While some 
commonalities were broadly identified, such as notions of control and (dis)empowerment, 
emergency contraception was unique with respect to the embodiment of these experiences and 
participants’ health care encounters. Once again, women in larger bodies described diverse 
experiences that ranged from somewhat neutral to profoundly negative, differing both within and 
across participants. The use of emergency contraception was rarely planned, and hence, 
participants’ experiences were often shaped by a heightened sense of urgency and the personal 
context surrounding their unprotected sexual encounters. In this chapter, I examine women in 
larger bodies’ experiences with emergency contraception and articulate the meanings ascribed to 
these experiences. I present my findings within the context of three major stages of this 
phenomenon: (1) Reacting to Unprotected Sex; (2) Accessing Emergency Contraception; and (3) 
Using Emergency Contraception. 
8.1 Reacting to Unprotected Sex 
8.1.1 Freaking Out 
 Women were frequently alarmed or distressed following unprotected sexual encounters 
that could result in unintended pregnancy. The extent to which participants “freaked out” often 
depended on the context of the incident. Some women needed emergency contraception because 
of contraceptive misuse or failure, such as a broken external condom; others indicated that 
contraception had not been used, typically out of impulsivity or by choice. Notably, most 





 Participants usually experienced a certain degree of anxiety, fear, or remorse following an 
unprotected sexual encounter. Some women blamed themselves, feeling as though they should 
have used contraception or been more careful. Marie, for instance, divulged how she felt after an 
experience where she had sex with a regular partner and contraception had not been used:  
I felt guilty for not having used a condom, I felt stupid because I knew 
better than to have unprotected sex, I felt scared that one stupid decision 
could hurt the life I’d built myself, and I felt upset about all of the above.  
Like Marie, some participants dreaded how an unintended pregnancy could impact their lives. 
Antara had multiple experiences using emergency contraception and described the worry that she 
expressed after each unprotected sexual encounter:  
I had school, I had work, […] it was a lot of anxiety about that as well. 
Anxious, I became very anxious. Uh, nervous, uncertain .. and then 
panic, like I need to get rid of this, I need to – I need to take care of this. 
Like, I’m not in a good place to bring – be pregnant.  
Although she could not change what had happened, by referring to the need to “get rid” or “take 
care” of the situation, Antara articulated a sense of personal responsibility to seek emergency 
contraception and maintain control of her future. 
 Some women felt more upset or at ease due to the personal circumstances surrounding 
their unprotected sexual encounters. While participants sometimes described instances where 
they engaged in unprotected sex with regular or committed partners, casual encounters were also 
reported, which contributed to heightened feelings of discomfort and distress. For example, 
Kendra felt “awful” after a condom slipped off with a new casual partner. Kendra left for the 
pharmacy without discussing the incident with her partner, as she wanted to “take care of [the 
situation] just in case” and thought: “I probably don’t want to ever see this person again.” Some 





sexual violence, resulting in intensified pain, fear, and urgency, as demonstrated by a few of the 
participant stories described in Chapter 5. Overall, the context surrounding unprotected sex had a 
pronounced impact on how distressed women in larger bodies felt as they entered the health care 
system to access and use emergency contraception, thus shaping how their experiences became 
embodied.  
8.2 Accessing Emergency Contraception 
 Most participants accessed emergency contraception within the first 24 to 48 hours after 
sex. While many women experienced anxiety when doing so, they were typically confident in the 
decision to seek emergency contraception. Several participants cited the out-of-pocket expense 
when conveying their experiences, with many participants taking sole responsibility for the cost. 
Nonetheless, most participants agreed that emergency contraception was easy to access in terms 
of its pharmacy availability, albeit their feelings while doing so and perceptions of the care they 
received varied.  
8.2.1 Feeling Embarrassed and Ashamed 
 Discomfort accessing emergency contraception often manifested as feelings of 
embarrassment or shame. Like routine contraceptive care, several participants described 
instances where they felt stigmatized when seeking emergency contraception. Internalized 
negative attitudes about sexual activity had a compounding effect on stigmatization, as 
participants entered the health care system, as Marie put it, “from a place of like, almost deficit.” 
Quinn, who advocated for sex-positivity, shared an experience where they sought emergency 






I just remember feeling like, just embarrassed and ashamed and like […] 
the second it is just me and another professional, I just like – I feel like, 
all that internalized stuff comes out. Like, Catholic upbringing that I just, 
like, “Nope! You should feel ashamed, you’re gonna feel ashamed.” 
Like, “No, no, it’s fine, it happens.” Like, “No! Shame.” So I just felt, 
like, just really disappointed in myself too, like, you couldn’t fucking – 
like, we’re here again. (Chuckles) I was just mad at myself. 
Citing the religious context in which they were raised, Quinn explained that despite their best 
efforts, shame was deeply embedded within their attitudes towards sex and thus continued to 
impact their experiences. Similarly, Beyoncé’s shame about her engagement in unprotected sex 
made her believe that others would judge her as well. Reflecting on her four experiences with 
emergency contraception, Beyoncé described going to the pharmacy to purchase Plan B®:  
[I was] definitely not feeling good. Uh, it was a little bit embarrassing, 
um, I just remember feeling like, um, uh (chuckles) like the pharmacist 
knew that I’d made a mistake. […] I guess I felt like a little bit [of] uh, 
shame around that. 
Although Beyoncé stated that she had minimal interaction with the pharmacist on each occasion, 
she felt judged by virtue of requesting emergency contraception, as it revealed her “mistake.”  
 Furthermore, while many participants felt ashamed when they went to the pharmacy 
alone, a few women were accompanied by a friend or partner for support. Two participants 
recalled instances where they asked their partners to purchase emergency contraception on their 
behalf because they were too embarrassed to enter the pharmacy. Sultana, who preferred that her 
partners accessed Plan B®, highlighted the differences in their interactions with pharmacists:  
I remember when one of my partners picked it up, like picked up the Plan 
B, he was like, “Oh, no one said anything” – to him. I’m like, “Well, 
good for you.” Like, lucky you (chuckles). […] I am the only one who 
get[s] like, get[s] like the whole, the stare like top to bottom. And then 
[the pharmacists will] be like, “Okay sure,” like, “We can get it for you.” 





This quote is interesting, as both Sultana and her partner described relatively transactional 
encounters; however, Sultana observed non-verbal judgement from pharmacists when she 
requested emergency contraception. By stating, “I am the only one,” Sultana implied that 
although two parties are implicated in an unprotected sexual encounter, women bear the 
responsibility and moral judgements that are projected by others, or in this case, pharmacists. 
This sentiment was echoed by a few participants who perceived judgmental verbal and non-
verbal microaggressions from health care providers involving condescending looks, tone of 
voice, or comments. For instance, Antara preferred to avoid the pharmacy in her neighbourhood, 
as she often felt shamed by a pharmacist who always asked her “a million questions.” The notion 
of privacy was also identified by some women who wanted to avoid being recognized. Indeed, 
participants generally felt more embarrassed when they had to interact with health care providers 
to purchase emergency contraception, which was frequently the case, as participants rarely 
reported accessing LNG-EC from the self-selection area of the pharmacy.  
 Additionally, two women described profoundly negative experiences where they felt 
humiliated and body shamed by health care providers. Though she felt anxious after her 
unprotected sexual encounter, Kendra had phoned a friend for support and was anticipating a 
transactional purchase when she proceeded to the nearest pharmacy. However, upon her arrival, 
Kendra was jarred when the pharmacist looked at her body, stated that Plan B® may not be 
effective due to her weight, and urged her to wait a few days to have a Cu-IUD inserted at a 
health clinic instead. Kendra believed that the pharmacist did not want to sell her Plan B® and 
characterized their 10-minute conversation as “the hardest thing [she had] ever, like, had to fight 
for.” While she noted that her friends never had any issues accessing emergency contraception, 





I’ve always been, like, overweight, I guess? I’ve kind of – since 
childhood, so it’s always been like something that’s on my mind, and I 
think it was just this, like, kind of, just kind of punch in the gut of like 
another reminder, um […] I wasn’t even close to a cut-off for what, like, 
they claim is – is kind of, um, the healthy weight. […] I think I was also 
kind of embarrassed by that, to be like, well, if I go talk to my friends 
about this, then they’ll all know that I’m over, you know, 200 pounds. 
[…] I think as I was getting more confident dating and stuff, reminding 
myself that like, your weight isn’t a definition of who you are, kind of 
thing. And like, building that confidence and then, like, be reminded 
again. It was just – it was awful. […] Like, all that stuff that I was 
learning [about BMI not being an indicator of health], kind of like, it just 
came right back to a number. So, it was just kind of, a lot of growth, kind 
of felt, you know, crushed at that moment. 
Having previously stated that she cannot drive past the pharmacy now without thinking about 
that “terrible morning,” this quote highlighted the devastating impact that Kendra’s experience 
had on her body image and self-esteem. Coupled with Alice’s experience described in Chapter 5, 
these concerning findings emphasize the important role pharmacists play in the delivery of 
weight-related information.  
8.2.2 Transactional Encounters 
 Despite the pervasiveness of the overarching anxiety that women experienced 
surrounding unprotected sex, several participants characterized their resulting health care 
encounters as merely transactional. These women often described brief interactions with 
pharmacists where they purchased emergency contraception with relative ease. Such 
transactional encounters were prevalent among participants who had used emergency 
contraception multiple times. 
 Participants sometimes recounted instances where pharmacists asked them how much 
time had elapsed since unprotected sexual intercourse, if they had used emergency contraception 





emergency contraception were relatively unnoteworthy, as she explained: “I just asked the 
pharmacist for Plan B. Um, I did not ask any other questions, and he didn’t ask me any 
questions. And [I] just paid and went.” Participants also described transactional encounters 
where they felt somewhat at ease, as women were sometimes more comfortable when they were 
accompanied by someone else, they were not in their own neighbourhood, LNG-EC was 
available in the self-selection aisles, or they did not perceive any judgement from others. When 
Ivy accessed Plan B® as an adult, she stated that the pharmacists “just sort of assume that you 
know what you’re there for,” and asserted: 
I think with emergency contraception, it was quite, just, transactional. 
Especially since I went with my partner. They were just kind of like, 
“Alright, here. Do you know how to use this?” “Yes.” “Alright, cool.” 
Like, it’s a very different experience than getting the actual birth control 
pill. They – they seem to understand the urgency, and so they just hand it 
over (chuckles). 
Given that Ivy felt anxious when accessing Plan B® in her youth and believed that routine 
contraception was too heavily monitored, she appreciated the transactionality and “urgency” 
surrounding her recent experiences accessing emergency contraception. Thus, although LNG-EC 
was typically kept behind the counter, participants still appreciated its availability as a non-
prescription medication. 
8.2.3 The Effects of Being (Un)Informed  
 There was variation in the breadth and depth of emergency contraceptive counselling and 
information provided to women by health care providers. While participant knowledge varied 
and some women had inaccurate or incomplete information, all participants had a basic 
understanding that, as Alice stated, “if something goes wrong, you take Plan B.” Participants 





contraception for the first time, such as how to use it, side effect profile, timing-related efficacy, 
and for a few participants, weight-related efficacy. As a result, some women who had accessed 
emergency contraception more than once felt confident in their ability to use LNG-EC and did 
not necessarily seek out or feel that they needed much additional information on subsequent 
occasions. In comparison, two participants decided to seek specialized information and 
counselling from doctors when they needed emergency contraception again. 
 Several participants sought more information about emergency contraception on their 
own rather than from health care providers. Some women read the medication package insert, 
searched the Internet, or consulted with friends to discuss their experiences. Beyoncé recalled 
using an online search engine and reading the medication label to learn how to use Plan B® 
when she purchased it for the first time. She later noted: 
I think if I had a better education around, for example, um, emergency 
contraception, um, beforehand, I wouldn’t have been so, like, panicky the 
first time, and so worried. And it would have been less, um, I think 
embarrassing just to go, um, into a pharmacy and ask for emergency 
contraception. 
In addition to feeling ashamed of her sexual activity, this lack of education further contributed to 
Beyoncé’s embarrassment, which may have in turn prevented her from seeking information from 
the dispensing pharmacist. While most participants felt more assured after seeking further 
information, Barbara described an instance where she became confused. When Barbara needed 
emergency contraception for the first time, she was afraid of being recognized, so her partner 
went to the pharmacy to purchase Plan B® on her behalf. Unfortunately, he could not remember 
the pharmacist’s directions upon his return and even after reading the Plan B® package insert 





There was so many instructions, so then maybe I’m thinking, you know, 
maybe I read it wrong. You know, maybe it’s telling you, “Wait 24 hours 
to take it,” you know, after your experience or whatever. But I don’t 
know, I just didn’t understand it.  
Barbara asked a friend who had used Plan B® before, but received conflicting information, so 
she decided to take the medication right away and “let fate decide.” Given that she did not feel 
comfortable speaking with a pharmacist, Barbara’s first experience with emergency 
contraception was shaped by confusion and uncertainty. Together, Beyoncé and Barbara’s 
experiences highlighted the importance of education about emergency contraception, as these 
participants felt disempowered by the combined effects of their sense of shame and gaps in 
knowledge when first accessing this medication.  
 Of notable importance, several women in larger bodies expressed strong sentiments about 
being (un)informed of LNG-EC’s weight-related efficacy. All participants who used emergency 
contraception in the last five years were aware of the LNG-EC weight advisory at the time of the 
interview; however, this information was rarely communicated to them by pharmacists when 
they accessed emergency contraception. Women recalled learning about the weight warning 
from a variety of different sources, including school, the media, friends, the LNG-EC label, and 
sometimes, health care providers. Participants were often left feeling shocked, anxious, afraid, or 
upset, and Gia Grace expressed that this advisory “alienate[d] plus-sized women” by positioning 
their bodies as unworthy of care. She further declared: “this is something else that there appeared 
to be available to all women. But really, not all women.” While some participants accepted this 
information, learning about the weight warning sometimes prompted participants to consult with 
other women or seek more information online. Two participants later inquired about LNG-EC’s 





as demonstrated by Sultana, who was merely advised that weight loss may help to alleviate her 
concerns about weight-related efficacy.  
 Some participants who had used LNG-EC after the Canadian label requirements were 
introduced in 2014 felt disillusioned knowing that their health care providers failed to share this 
information with them. This lack of communication directly impacted Marie’s second experience 
with LNG-EC, as she “freak[ed] out” when she read the weight warning on the package insert 
shortly after leaving the pharmacy. Reflecting on the information (or lack thereof) that she 
received, Marie asserted: 
[W]hen the pharmacist didn’t tell me or, like, no one said anything or it’s 
not, like, in big letters somewhere, that emergency contraception is not 
effective for people who weigh over 165 pounds, like .. again, that was 
just a big shock and it – I, yeah. I felt like that was insufficient. And, 
again, bordering on, like, negligent because, like, sure, I’m sure lots of 
people weigh under 165 pounds but also lots of people weigh more than 
that. […] Yeah, I guess it’s just in a society that, like, really values 
thinness, especially with women. It just highlights the issue and yeah, it 
really highlighted the issue but it’s also like, okay but does that mean that 
people aren’t – like certain people aren’t well worth good health care? 
By referring to the pharmacist’s inaction as “insufficient” and “negligent,” Marie suggested that 
health care providers had a responsibility to inform patients about the weight advisory, which 
was echoed by some other women. This experience further demonstrated how some participants 
perceived their bodies to be devalued by the health care system and society more broadly.  
 Unfortunately, many women appeared to be unaware of other options. While a few 
participants knew about either UPA-EC or the Cu-IUD, there seemed to be a common 
recognition among participants that Plan B® was the emergency contraception. Consequently, 
some women expressed a desire for better options or wondered, as Alice said, “if there is 





very ideal weight range” through her university courses. Although she characterized Plan B® as 
a “hit or miss,” Sultana used it several times thereafter and insisted: 
I literally don’t have any other choice though. Right? Like if there were 
other options, that would be nicer. If I had more options which were 
better, um, but I don’t. […] And then because I know that, like, it will not 
[work], so, rather than, like, waiting on the doctor and waiting for [a 
pregnancy test] I was like, “Okay, let’s just take it anyway. Maybe it will 
work.” And it’s just one of those things. 
Much like other participants, not only was Sultana uninformed by her health care providers about 
the weight warning, she was also unaware that LNG-EC is not the only available method of 
emergency contraception. Furthermore, by emphasizing that it “will not” work for her, Sultana’s 
lack of confidence in Plan B® intensified feelings of anxiety surrounding her emergency 
contraceptive use. This perception is significant given that some participants reported instances 
where they decided against using emergency contraception, in part, due to the weight advisory. 
While Kendra wanted to avoid another stigmatizing conversation about her weight, other 
participants felt that using emergency contraception would be futile. Quinn stated: “I’m gonna 
waste $45 to take a pill that’s gonna make me nauseous but not actually prevent pregnancy 
because I’m way too fat for it to be effective. So what’s the point?” These experiences and 
perceptions further demonstrated the importance of disseminating accurate information about 
emergency contraception, as some women in larger bodies may feel discouraged by the LNG-EC 
weight advisory, particularly if they lack proper awareness of all other options.  
 Finally, several women underscored the importance of how weight-related counselling is 
approached. As previously described, Kendra and Alice felt publicly humiliated after learning 





valued informed decision-making, but wished that the weight warning had been shared in a more 
sensitive manner, as explained by Kendra:   
I think just less of an emphasis on the weight, and that basically it wasn’t 
gonna work for me. I think if it was, you know, again, [I’m] used to 
pharmacists going through the kind of potential side effects or what to 
look out for, [I] wish it was just kind of brought up like that. Like, I 
understand that, you know, she probably had to tell me that [body weight 
may impact the efficacy of LNG-EC]. But if she could have just shared 
that information and let me make my own choice from there, [that] would 
have been, kind of more, I think, would have been the better way to go 
about it and I would have at least known that and then I could have made 
my own decision, or just been aware. 
Feeling as though her body had been weaponized, Kendra longed for respectful counselling to 
empower her to make an informed decision. The positive impact of supportive care was 
demonstrated by Barbara, who went to see a gynaecologist to discuss emergency contraception 
options following her most recent unprotected sexual encounter. Although the gynaecologist was 
surprised that Barbara was unaware of LNG-EC’s weight advisory, Barbara felt that this doctor 
provided honest and non-judgemental information. Barbara learned about different emergency 
contraceptive pills and their potential weight-related efficacy; the benefits, risks, and barriers 
associated with each option; and the gynaecologist’s recommendation. After learning that the 
ideal body weight range for ella® (i.e., UPA-EC) was also below her “weight class” and would 
take a few days to order, Barbara ultimately decided to purchase Plan B®. She still worried 
about whether LNG-EC would “work” for her, but this experience made Barbara feel well-
informed, validated, and confident in her decision. 
8.3 Using Emergency Contraception 
 Participants described taking emergency contraception shortly after leaving the 





their use of emergency contraception, whereas others discussed how their stress became 
embodied as they awaited menstruation. Overall, women’s experiences using emergency 
contraception were often shaped by their emotions leading up until they knew that they were not 
pregnant. 
8.3.1 Feeling Anxious and Unsure 
 In addition to lingering shame surrounding their unprotected sexual encounters, many 
participants continued to experience some anxiety after taking emergency contraception. While 
most women’s anxiety was related to the possibility of an unintended pregnancy, a few 
participants recounted instances where they were also tested for STIs and HIV and thus 
experienced elevated uneasiness until they received their results. Several participants recalled 
feeling restless following the use of emergency contraception. For example, Quinn described 
“counting down the seconds” until their next menses, whereas Barbara kept “checking” to see if 
her menstrual period had begun and frantically updated her friend, spouting: “I didn’t get it yet, I 
didn’t get it yet!” Such feelings of stress or anxiety sometimes became embodied and were 
believed to have exasperated physical effects, such as nausea, tension, and delayed menstruation. 
Kendra felt that her risk of pregnancy was low based on her menstrual cycle tracking, but she 
became increasingly worried following her hurtful experience at the pharmacy, as she recalled: 
I was, like, very anxious just to get my period and kind of put it all 
behind me. And again, like, anxiety plus periods don’t always work well 
either, so it’s kind of the, like, terrible effect of like, I think I ended up 
having a late period, just because I was so anxious about it, that my body 
kind of, like, the anxiety took over it. So yeah, it was – it was, like, a long 
three weeks of waiting. 
Kendra’s perception that her intense anxiety “took over” her body demonstrated the profound 





that participants embodied represented the culmination of their feelings towards the unprotected 
sexual encounter, their health care interactions, and finally, their use of emergency contraception.  
 Participants’ anxiety was further defined by uncertainty. When using emergency 
contraception for the first time, some women recalled feeling afraid, uneasy, or unsure about 
how the medication would impact their bodies. Multiple participants worried about or anticipated 
side effects, as illustrated by Barbara, who admitted that she expected “some whole big blood 
massacre” and “the worst pain ever.” A few participants also noted that they were particularly 
concerned about their painful menstrual symptoms or irregular cycles. Beyoncé always felt 
nervous after using Plan B® due to her PCOS, as she explained: “I already have irregular periods 
(chuckles), so, um, there was I think that extra worry because it could be late anyway.” As such, 
a missed or late menstrual period may or may not have been indicative of pregnancy.  
 Participants sometimes seemed unsure if they would menstruate at all, suggesting a lack 
of confidence in their use of emergency contraception or its efficacy. Some women recalled 
praying or accepting fate, as Sapphire explained: “just go and get the pill, and fingers crossed.” 
Participants felt uncertain for various reasons, such as recognizing that emergency contraception 
was not 100% effective, fearing they took it at the wrong time, worrying when their bodies did 
not react as expected, or their looming awareness of the weight advisory on LNG-EC. This doubt 
was expressed by Sultana, who always anticipated but never experienced nausea after using 
emergency contraception. Sultana described how she felt while awaiting menstruation:  
I was a bit more worried that like, um, I might have more side effects or, 
like, the typical effects that you usually have that comes as a result of 
Plan B. But that never happened, it just, like, left me more paranoid. As 
to, like, why it wasn’t happening, um, I also knew that, like, Plan B does 
not necessarily, like, work well with, like, someone who has, like, a 






 Sultana’s characterization of paranoia suggested that she was persistently disturbed by intrusive 
thoughts about the possibility of an unintended pregnancy. Likewise, most women who had been 
cognizant of LNG-EC’s weight warning at the time of use described feeling worried that their 
emergency contraception may or may not work. A few participants’ state of concern even 
prompted them to plan for or seek confirmation via a pregnancy test.  
8.3.2 Feeling Relieved 
 Fortunately, none of the participants became pregnant following their experiences with 
emergency contraception. Several participants expressed some initial relief after using 
emergency contraception, as they believed it had empowered them to take responsible and 
appropriate action to prevent unintended pregnancy. For instance, although Antara felt nervous 
while awaiting her next menstrual cycle, she also acknowledged: “this is the best I can do and 
I’m doing it.” As she further quipped, “It’s Plan B, it’s supposed to work!”, this self-assurance 
helped calm her anxiety. Some participants’ nonchalance was closely related to previous use of 
emergency contraception and the nature of their sexual relationships at the time. Reflecting on 
her second experience using LNG-EC, Gia Grace explained: 
I knew I was going to expect something [in terms of side effects]. Um, 
just being prepared and having a sense of what it was like before. I – I 
prepared my body and my mind for what was coming and so I feel like I 
was just a lot more calmer and at ease about it. 
By preparing her body and mind for the side effects of emergency contraceptive use, Gia Grace 
was able to keep her composure as she awaited her next menstrual period. Adding to this, two 
women noted that they took emergency contraception as soon as possible after unprotected sex to 
achieve maximum efficacy and offset some of the uncertainty they experienced due to the LNG-





 A few participants seemed to perceive side effects, like nausea or cramping, as validation 
that emergency contraception was “working.” However, most women did not feel complete relief 
until they knew that they were not pregnant, which was typically confirmed by late or heavy 
menses. Irrespective of whether their next menstrual cycle began or they took a pregnancy test, 
women often enthusiastically articulated their happiness to learn that they were not pregnant. 
Interestingly, some participants did not necessarily attribute this outcome to their use of 
emergency contraception, as Marie expressed: “It’s just like joy and like, ‘Okay, whatever – 
whatever happened worked’, whatever it was (chuckles).” Similarly, other participants briefly 
wondered whether emergency contraception had been needed at all, but expressed gratitude for 
their continued freedom from pregnancy and moved on. 
 Finally, the extent to which participants expressed relief sometimes depended on the 
personal circumstances surrounding their experiences. A few participants recalled instances 
where they were distracted by other issues that had arisen and taken priority. For instance, Ivy 
had “other important shit going on” and merely thought “alright, cool” when she menstruated 
after her most recent experience using Plan B®. Furthermore, two participants described 
situations where they were slightly saddened to learn that they were not pregnant. While Sultana 
had used LNG-EC multiple times and was generally “very, very relieved,” she specified that 
there was one instance where she felt “a bit emotionally low.” Given that she had been engaged 
to her partner at the time, Sultana mused: “maybe subconsciously I wanted [to be pregnant]?” 
Conflicting feelings were also expressed by Quinn, who was initially disappointed after 
romanticizing the idea of becoming pregnant with their codependent partner in college. In 
contrast, Quinn’s most recent experience involved a casual partner who “didn’t care” about 





EC, as well as STI and HIV testing. Quinn felt like “1000 pounds had been lifted off [their] 
shoulders” when they menstruated, but continued to feel worried and ashamed until they 
received their test results. Ultimately, Quinn reflected:  
[I was] [r]eally relieved. And then I felt guilty that I had really, like, so 
harshly judged myself with all of that internalized sex-negativity and 
slut-shaming, and all of those things. […] I just felt guilty for being so 
awful to myself, and then I just felt resolved that I was like, “Okay, I 
need to, again, figure something else out [to prevent pregnancy], I need 
to create better boundaries and find better partners who are going to 
support me through things like this, ‘cause fuck that guy!” And 
(chuckles) I was like, “Okay! I really need to get my tubes tied, because 
this is baloney and I’m not doing this again.” 
Given that Quinn was non-monogamous and unable to find a satisfactory method of routine 
contraception, as discussed in Chapter 6, they were determined to avoid using emergency 
contraception ever again. Overall, the diversity of participants’ reactions to learning that they 
were not pregnant highlighted the impact of the personal circumstances surrounding women in 
larger bodies’ experiences with emergency contraception. 
8.4 Summary 
 In this chapter, I analyzed participants’ experiences accessing and using emergency 
contraception. Although diverse and context-dependent, the findings revealed that women in 
larger bodies’ experiences often involved varying degrees of shame, anxiety, and uncertainty. 
Women’s perceptions of their pharmacy interactions ranged from transactional to stigmatizing. 
Participants had typically received some information from pharmacists about LNG-EC, albeit 
this rarely included weight-related efficacy. Finally, while most participants ultimately 
experienced relief, women were not always confident in their use of emergency contraception 





Chapter 9: Discussion 
 This study explored the lived experiences of women in larger bodies who access and use 
female-oriented contraception in Ontario. The findings revealed significant variation in 
participants’ experiences with routine and emergency contraceptive use and care, including their 
embodied sense of control when using contraception, feelings of (dis)empowerment throughout 
contraceptive care, and the role of personal context in shaping these experiences. 
Disempowerment often pertained to participants’ impressions of stigma and unmet contraceptive 
care needs, whereas empowerment stemmed from perceptions of supportive care. Overall, my 
analysis demonstrated the unique and diverse nature of the meanings that women in larger bodies 
assigned to their experiences with contraception.  
9.1 Key Findings 
  One of the key findings from this study was the notion of control, which underpinned 
women in larger bodies’ embodied experiences with contraception. While emergency 
contraceptive use was often characterized by feelings of anxiety and uncertainty, participants’ 
sense of bodily control when using routine contraception was complex and multidimensional, as 
women shared stories of seeking, negotiating, achieving, and sometimes, spiralling further out of 
control. The anticipated control gleaned from routine contraception was merely a convenience 
for a few participants, whereas others were menaced by the unruliness of their bodies. In this 
way, participants’ embodied experiences with contraceptive use sometimes exemplified the 
perception that women’s bodies are simultaneously uncontrollable and in need of control (151). 
For instance, many women in larger bodies expressed negativity towards their menses and 
experienced irregular, painful, or otherwise bothersome menstrual cycles and symptoms. While 





continuously reminded of their bodies’ boundlessness by the pervasiveness of their menstrual 
irregularities. Furthermore, many participants vividly described the physical and mental effects 
that accompanied their contraceptive use. These changes revealed the significance of corporeal 
experiences to the process of contraceptive embodiment and hence, women in larger bodies’ 
embodied sense of control. I situate these findings within a paradoxical discourse proposing that 
contraception both offers and constrains women’s reproductive and bodily autonomy (52–
54,152,153). 
 Research has previously suggested that the notion of control is central to contraceptive 
decision-making and management (54,57,58,67,68,152,154). However, fewer studies have 
focused on examining how control (or lack thereof) becomes embodied through contraceptive 
use (68), and little is known about the lived experiences of women in larger bodies in particular 
(22). By focusing on embodiment, my study adds to this literature by illuminating the intricacies 
of the relationship between women in larger bodies’ contraceptive use and their embodied sense 
of control. Some women felt empowered by the control they achieved with their first 
contraceptive, but many participants became dissatisfied with concerning side effects, the 
absence of beneficial effects, or method inconvenience. Akin to studies that have articulated how 
unwanted side effects may threaten women’s sense of bodily control (58,67,68), method 
dissatisfaction was often associated with embodied feelings of disarray, which prompted 
participants to seek a new contraceptive or discontinue use. Intriguingly, the opposite seemed to 
be true for emergency contraceptive use, as various participants expected side effects and 
perceived them to be an indication of efficacy. Nonetheless, in some instances, women chose to 
tolerate certain aspects of their routine contraceptive use, such as painful IUD insertions, thereby 





 Routine contraceptive use often became normalized over time among long-term users, 
and as such, some women came to understand their bodies through the lens of their contraceptive 
use. For instance, some participants became accustomed to the hormonal influx and began to 
recognize their bodies as “normal” when using contraception, whereas other women’s 
contraceptive use perpetuated a sense of bodily disorder. The notion of long-term normalization 
was thus an interesting finding, as participants were able to achieve some semblance of control 
through the routinization of contraceptive use, even when their bodies continued to feel unruly. 
While previous research has demonstrated that contraceptive preferences and use may change 
with age, context, and experience (69,155), to my knowledge, less attention has been paid to the 
normalization and embodiment of contraceptive use over time, thus representing compelling 
potential directions for future research.  
 In exploring how women in larger bodies navigated contraceptive care, I found that 
participants were disempowered by stigmatizing experiences. Perhaps unsurprisingly, 
participants most often experienced stigma surrounding their contraceptive use (e.g., sexual 
activity, sexual and reproductive health) and weight. Participants who described internalized 
negative attitudes fostered a sense of discomfort that manifested throughout their experiences 
with contraceptive care. Additionally, previous stigmatizing health care experiences sometimes 
incited distrust or avoidance of health care providers. Several women also shared experiences 
where they observed stigmatizing behaviour from prescribing or dispensing health care providers 
during contraceptive care, leading to feelings of shame or judgement. For example, some 
participants described instances where their weight was unwantedly or inappropriately discussed. 





reproductive health care (7,9–14) and reinforces previous research inferring that women in larger 
bodies’ contraceptive use and care may be hindered by stigma (117,128,131).  
 In particular, my findings provide evidence that women in larger bodies may face 
intersecting stigmas throughout their experiences with routine and emergency contraceptive care. 
A recent study by Holland et al. (156) suggested that multiple internalized stigmas towards one’s 
body, including body shape, menses, and genitalia, may contribute to discomfort when speaking 
with health care providers and avoidance of sexual health care. My study further suggests that 
women in larger bodies’ engagement with contraceptive care may be influenced by overlapping 
forms of internalized and perceived stigmas not exclusively limited to their bodies, but also to 
their assumed and actual sexual behaviours. Lastly, I found that stigmatization was further 
shaped by participants’ various social identities or practices, such as ethnic, cultural, or religious 
background, non-monogamy, and sexuality. This finding complements recent research 
investigating how body size interacts with other axes of marginalization in reproductive health 
care (9,13). 
 In accordance with research on how health care utilization is shaped by weight bias (93) 
and the findings from Holland et al. (156), participants who experienced stigma did not always 
fully engage with their contraceptive care. These participants sometimes described avoidant 
behaviours, such as concealment of information surrounding their contraceptive use, an 
unwillingness or inability to discuss all their contraceptive needs or concerns, and at times, 
complete avoidance of contraceptive care. What is more, experiencing stigma in multiple ways 
had a compounding effect on how certain women in larger bodies interacted with contraceptive 
care. While the findings from this study call for research on women in larger bodies’ experiences 





need for inclusive care approaches that are non-judgemental and trauma-informed. Tailored anti-
stigma and weight neutrality training (e.g., Health At Every Size® (157)) may be appropriate 
first avenues that could be explored to better equip health care providers to offer unbiased, 
shame-free, patient-centred contraceptive counselling and care to women in larger bodies.  
 To exemplify the impact of multiple stigmas, learning about LNG-EC’s weight-related 
efficacy sometimes reinforced the notion that larger bodies are devalued in society (87). Given 
that women typically experienced some degree of embarrassment or shame surrounding their use 
of emergency contraception, a sentiment that is well-documented in the literature (45,71,72,74), 
participants who learned about the weight warning when seeking LNG-EC often described 
experiencing enhanced feelings of stigmatization or anxiety. A few participants consequently 
questioned whether their bodies were unworthy of care. Of notable importance, negative 
perceptions sometimes led to subsequent non-use of emergency contraception when participants 
believed that LNG-EC would be ineffective or wished to avoid potentially stigmatizing 
conversations about their weight. Unfortunately, several participants were unaware of other 
options, which is commensurate with a study where Ontario pharmacists indicated that most 
women specifically request Plan B® rather than “emergency contraception” or a Cu-IUD (49). 
As women in larger bodies may consider weight-related efficacy when selecting a method of 
emergency contraception (121), my findings accent the need to improve the provision of 
emergency contraceptive information and counselling. Public health and clinical efforts are 
necessary to increase awareness of all emergency contraceptive options, including UPA-EC and 
Cu-IUDs, and ensure that accurate information about weight-related considerations is delivered 
in a respectful, sensitive manner such that women in larger bodies do not feel discouraged from 





 Researchers have also articulated how weight bias and stigma may impair the quality of 
care offered to individuals in larger bodies (94,95). In a similar manner, health care providers 
may restrict women’s contraceptive agency through the care they provide – or rather do not 
provide (154,158). Consistent with a recent scoping review proposing that women in larger 
bodies may receive inadequate contraceptive counselling and care (22), many participants 
implied that their contraceptive care needs were not always met.  
 Women described paternalistic contraceptive care encounters where they felt dismissed 
by health care providers who rushed their appointments or did not truly listen to their concerns. 
For instance, some participants felt pressured to (not) use a certain method, referred to 
contraception as a “band-aid solution” whereby little effort was made to investigate their issues 
further, or felt frustrated when their health care providers failed to consider their expressed needs 
and experiences with contraceptive use. When participants felt dismissed, they sometimes 
conceded to their health care providers’ authority or learned to self-advocate and take control of 
their contraceptive care. Moreover, several women wished they had received more contraceptive 
information and resources from their health care providers. Participants reported experiences 
where they were not fully informed about the complete range of contraceptive options and 
received minimal explanation of the methods they were prescribed, which often prompted 
women to seek information elsewhere. Health care providers also rarely discussed weight 
considerations when women in larger bodies sought LNG-EC, representing a significant gap in 
care that warrants further research. Congruent with some of these findings, Gomez and 
Wapman’s (158) study with young Black and Latina women proposed that an authoritarian 





how they engage with contraception. As such, my findings underscore the importance of 
improving the quality of contraceptive care offered to women in larger bodies.  
 Nonetheless, it was encouraging to learn that many women felt supported in some 
capacity. Several participants reported at least one positive experience where they felt 
empowered through patient-centred contraceptive care. Specifically, women in larger bodies 
valued non-judgmental health care providers who offered comprehensive information and 
approached contraceptive care in a collaborative manner, wherein participants played an active 
role in discussions and decision-making. These findings echo some of the contraceptive 
counselling preferences previously reported by women in Western countries (62) and the 
SOGC’s clinical practice recommendations (111).  
 Overall, the provision of high-quality, non-judgemental, equitable contraceptive and 
reproductive health care for women in larger bodies is critical for achieving reproductive justice. 
This study offers valuable insight into some of the challenges that women in larger bodies may 
face during routine and emergency contraceptive care and use, while also celebrating the 
compassionate, inclusive, and empowering care that some participants received from their health 
care providers. My findings highlight the value of and need for non-stigmatizing, patient-centred 
approaches to support women in larger bodies to make informed contraceptive decisions. In 
addition to facilitating open discussions with patients about their contraceptive care needs and 
preferences, I suggest that health care providers explain the full range of contraceptive methods 
and include emergency contraception in routine contraceptive counselling. In keeping with 
Canadian clinical guidelines, the use of LNG-EC should not be discouraged based on body size; 
however, women in larger bodies should be adequately informed about weight-related efficacy 





options (111). I further propose that women in larger bodies may benefit from being offered an 
advanced prescription of UPA-EC and information about access to prompt or same-day Cu-IUD 
insertions. This suggestion would encourage timely access to highly effective methods of 
emergency contraception when needed, if desired. By taking a sensitive and holistic approach to 
contraceptive counselling and care, health care providers can help improve the experiences of 
women in larger bodies. 
9.2 Limitations  
 Although this study offers novelty by using a qualitative approach to explore women in 
larger bodies’ lived experiences with contraception, it is not without limitations. IPA lends itself 
to relatively small, homogeneous study samples (146), and thus the large sample size and vast 
range of experiences documented in this study posed some analytic limitations. I attempted to 
capture diversity, but it was challenging to convey all the complexities and nuances of the lived 
experiences of 19 participants within this thesis. To further illustrate the mosaic of experiences 
and their respective meanings, future research could independently examine women in larger 
bodies’ use of individual methods of female-oriented contraception to provide a comprehensive 
account of each of these embodied experiences. A narrower focus could also help to understand 
women in larger bodies’ experiences using various short-acting barrier methods of contraception 
that were not captured in this sample of participants (e.g., diaphragm, internal condom).  
 Despite the significant diversity in participants’ lived experiences, it is important to 
consider the social privileges represented within the study sample. Participants were highly 
educated; predominantly urban-dwelling, white, and heterosexual; and most participants stated 
that they had insurance to fully or partially cover the cost of routine contraception at some point 





noted that other women (e.g., women whose bodies were larger than theirs, women of colour, 
uninsured or rural women) might face greater challenges when accessing contraception. 
Individuals in larger bodies with multiple marginalized identities may also experience more 
profound weight stigma (159), and hence it is crucial that future research further examines the 
experiences of women in larger bodies who have various intersecting identities and characterizes 
the unique challenges that they face. To gain a better understanding of how overlapping 
marginalized identities shape women in larger bodies’ lived experiences with contraception, 
succeeding studies would benefit from an intersectional approach and analysis, as conceptualized 
by Crenshaw (160), which would be better suited to tease out the intricacies and nuances of 
multiple forms of oppression. Recently, scholars have drawn attention to the value of 
approaching intersectionality through a reproductive justice lens when examining reproductive 
health experiences, including those pertaining to contraception (153,154) and women in larger 
bodies (9,13). This lesser-used framework considers how various dimensions of social power and 
inequality are ingrained within issues related to sexual and reproductive experiences (153) and 
should thus be prioritized when designing future studies. 
 The exclusive focus on individuals who identify as women and use female-oriented 
contraception is a notable limitation of this study. One participant explained that while the term 
“woman” resonated with them in some ways, they described their gender as “femme” and used 
they/them pronouns. Indeed, contraception is used across the gender spectrum and thus, the use 
of gendered language (i.e., “women,” “female”) in the eligibility criteria and recruitment 
materials excluded some transgender and gender diverse individuals from participating in this 
study. This focus was chosen in consideration of the research design, the relatively homogenous 





contraception and larger bodies (54,143). Also, studies suggest that transgender and non-binary 
individuals may have unique contraceptive needs, considerations, and experiences (161,162). In 
line with the previous recommendation for intersectional inquiry, more inclusive study designs 
are needed and future research should seek to explore the experiences of transgender and gender 
diverse individuals in larger bodies who use contraception.  
 Finally, by the nature of conducting qualitative research, it is important to acknowledge 
that the findings from this study are not meant to be generalized to the greater population of 
women in larger bodies (134). It is further worth recognizing my role in making interpretations 
through the “double hermeneutic” (146), in which case I may have misinterpreted, 
overaccentuated, or underemphasized some aspects of women in larger bodies’ experiences as I 
examined and reconstructed their stories. As the researcher, I have presented the features of 
participants’ experiences that I found to be the most meaningful or impactful based on my 












Chapter 10: Conclusion 
 Women in larger bodies are an important population of contraceptive users, yet they 
remain underrepresented in contraceptive research. This study aimed to understand the lived 
experiences of women in larger bodies who access and use female-oriented contraception in 
Ontario. My findings begin to fill a significant gap in the academic literature and the Canadian 
context by offering the first detailed account of women in larger bodies’ lived experiences with 
routine and emergency contraceptive use and care, highlighting the complexity and diversity of 
these experiences. Building on the SOGC’s call for comprehensive contraceptive counselling on 
a variety of contraceptive options and timely access to emergency contraception for all women 
(111), the recommendations derived from this study suggest how to better support women in 
larger bodies who access and use contraception. With the support of the current literature and 
any future studies that may follow, the findings from this research may be used to help develop 
clinical practice guidelines or inform health policy to bolster the expansion of information and 
access to highly effective methods of contraception for women in larger bodies in Ontario and 
across Canada. In this way, contraceptive care can be improved for women in larger bodies with 
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Appendix C – Information-Consent Form 
Letter of Information and Consent 
Title of the study: Exploring the lived experiences of women in larger bodies who access and 
use contraception in Ontario 
Faculty Supervisor: Elena Neiterman, PhD, School of Public Health and Health Systems, 
University of Waterloo. Phone: (519) 888-4567 ext. 38221, Email: eneiterman@uwaterloo.ca 
Student Investigator: Tierney Boyce, MSc Student, School of Public Health and Health 
Systems, University of Waterloo. Email: tierney.boyce@uwaterloo.ca 
Dear Potential Participant, 
To help you make an informed decision regarding your participation, this letter will explain what 
the study is about, your rights as a research participant, and the possible risks and benefits 
associated with participating in this research. If you do not understand something in the letter, 
please ask Tierney Boyce prior to consenting to the study. You will be provided with a copy of 
the information and consent form if you choose to participate in the study.  
What is the study about? 
You are invited to participate in a study conducted by Tierney Boyce, as part of her Master’s 
thesis research at the University of Waterloo. The purpose of this study is to learn about the 
experiences of women in larger bodies who access and use contraception in Ontario. Women are 
often the users of contraception, whether that be for birth control or for other reasons. There are 
many options available, and women may look to find the best fit for them. In Canada, we have 
many women living in larger bodies. However, there is little known about the experiences of 
women in larger bodies who access and use contraception. This study will examine the lived 
experiences of accessing contraception or receiving contraceptive care, explore the use of female 
methods of routine or emergency contraception, and learn about how women feel during and 
about these experiences. The ultimate goal of this study is to suggest how contraceptive care can 
be improved for women in larger bodies. 
I. Your responsibilities as a participant 
If you decide to volunteer, you will be asked to take part in an individual interview that will take 
approximately 60 minutes. The interview will be scheduled at a date and time that is convenient 
for you and will take place online (e.g., Skype, WhatsApp, MS Teams) or via telephone. Privacy 
cannot be guaranteed when information is transmitted over the Internet. There is always a risk 
your responses may be intercepted by a third party (e.g., government agencies, hackers). 
University of Waterloo researchers will not collect or use internet protocol (IP) addresses or 
other information which could link your participation to your computer or electronic device 
without first informing you. If you prefer not to participate using this online method, please let 





At the beginning of the interview, you will be asked to introduce yourself and answer some 
demographic questions, including your age, your ethnicity, whether you live in a rural or urban 
setting, your level of education, and your sexual orientation. You will then be asked open-ended 
questions that will focus on your experiences accessing and using contraception, such as 
receiving contraceptive counselling and how your body feels when using contraception. In 
general, you will be asked to share your experiences and feelings about the contraception you 
have used, the contraceptive care you have received, and what these experiences mean to you. 
The interview will be audio recorded to ensure an accurate transcript. With your permission, 
anonymous quotations may be used in publications and/or presentations. 
Who may participate in this study? 
To participate, you must be a woman (i.e., aged 18+) who speaks and understands English. 
Additionally, you must meet the following criteria to be eligible to participate in this study: 
1) You must identify as living in a larger body  
2) You must have accessed and used a female method of contraception* (or emergency 
contraception) in Ontario within the last five years 
3) You must have Internet or telephone access 
*What is considered female contraception? Female birth control refers to any methods that are 
used by women and their bodies. We are looking for women who have used at least one of the 
following methods:  
➢ Oral contraception (birth control pills) 
➢ Intrauterine devices or systems (copper or hormonal IUD/IUS for example, Mirena®) 
➢ Contraceptive patch  
➢ Contraceptive injections (‘the shot’, for example, Depo-Provera®) 
➢ Contraceptive implant (for example, Nexplanon®) 
➢ Vaginal ring (for example, NuvaRing®) 
➢ Female condoms 
➢ Diaphragm 
➢ Cervical cap 
➢ Contraceptive sponge 
➢ Emergency contraception pills (‘morning after pills’, for example, Plan B® or ella®) 
If you have any questions about eligibility for this study, please contact Tierney Boyce at 
tierney.boyce@uwaterloo.ca.  
II. Your Rights as a Participant 
Is this study voluntary? 
Your participation in this study is completely voluntary. You may decide to leave the study at 
any time prior to or during the interview by communicating your request to the researcher. 
During the interview, you may decline to answer any question(s) you prefer not to answer by 
requesting to skip a question. Following the interview session, you may completely withdraw 





Will I receive anything for participating in this study? 
You will not receive payment for your participation in this study. 
What are the possible benefits of this study? 
Participation in this study may not provide any personal benefit to you, but the findings from this 
study will enhance our understanding of women in larger bodies’ contraceptive experiences and 
needs, and may be used to inform future research. The knowledge gained from this study may 
one day be used to contribute to the development of clinical practice guidelines, policy, or make 
recommendations on how to improve contraceptive care in Ontario. 
Are there any risks to participating? 
The risks of participating in this study are considered minimal, but you may feel mild discomfort 
talking about your personal experiences with contraception and contraceptive care. We have 
attempted to minimize this risk by asking broad, open-ended questions that will allow you to 
share your experiences at your own pace and on your own terms. You may decline to answer any 
of the interview questions, and the interview can be paused or discontinued at any point. Sexual 
health, health advice, and mental health resources will be available, if wanted, to support you 
after your participation. 
Will my personal information remain confidential? Will I be identifiable? 
Your confidentiality is a priority throughout this research. 
Your verbal consent will be stored as a separate audio file and will be encrypted and stored on 
the researcher’s password-protected laptop. With your permission, we will gather some of your 
demographic information, such as your age, ethnicity, geographic setting (i.e., rural or urban), 
education level, and your sexual orientation. To ensure the confidentiality of your data, you will 
be identified by a participant pseudonym, which you may choose.  
With your permission, the interview will be audio-recorded to facilitate the accurate collection of 
information, and later transcribed for analysis. Within this audio-recording, your name will not 
be used, but your voice may be heard. The audio recording collected during this study will be 
destroyed immediately upon transcription (within two weeks of the interview) and only the 
anonymized transcript from the interview will be retained. All information that could identify 
you will be deleted from the interview transcript. Only the research team will know which data is 
from your participation, and any identifying information will be kept separate from the data. 
Only researchers associated with this study will have access to any study records. Your interview 
transcript will be stored separately under an anonymous participant code, encrypted and stored 
on a password-protected laptop, which is only available to the researcher. Encryption of 
electronic files will be conducted according to University of Waterloo IST policy. Any paper 
data (i.e., researcher notes) will be stored in a secure location. We will keep your data for a 
minimum period of seven years following the date of the interview, after which it will be 






III. Questions, Comments, Concerns 
How is this study funded? 
This study has not received any funding and there are no conflicts of interest to declare. 
Has the study received ethics clearance?  
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee (ORE #42481). If you have any questions for the Committee, please 
contact the Office of Research Ethics at (519) 888-4567 ext. 36005 or ore-ceo@uwaterloo.ca.  
Who should I contact if I have questions about my participation in the study? 
For all other questions regarding this study, or if you would like additional information to assist 
you in reaching a decision about participating, please contact me by e-mail at 
tierney.boyce@uwaterloo.ca. You can also contact my supervisor, Dr. Elena Neiterman, at   
(519) 888-4567 ext. 38221 or email eneiterman@uwaterloo.ca 
Yours sincerely, 
Tierney Boyce 
School of Public Health and Health Systems 





















I have read the information presented in the information letter about a study being conducted by 
Tierney Boyce, under the supervision of Dr. Elena Neiterman. I have had the opportunity to ask 
any questions related to this study, to receive satisfactory answers to my questions, and any 
additional details that I wanted.  
I am aware that I have the option of allowing my interview to be audio recorded to ensure an 
accurate recording of my responses. 
I am also aware that the excerpts from the interview may be included in the findings of this study 
with the understanding that the quotations will be anonymous. 
I was informed that I may withdraw my consent at any time by advising the researchers.  
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee (ORE #42481). I was informed that if I have any questions, I may 
contact the Office of Research Ethics, at (519) 888-4567 ext. 36005 or ore-ceo@uwaterloo.ca. 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this study. 
□ YES □ NO 
I agree to have my interview audio recorded.  
□ YES □ NO 
I agree to the use of anonymous quotations in future research projects/publications developed 
from this project. 
□ YES □ NO 
I give Tierney Boyce permission to retain the transcript from my interview for a minimum period 
of seven years and use it for research purposes as long as it has no identifiable information that 
ties it to me.  
□ YES □ NO 
By agreeing to participate in this study, you are not waiving your legal rights or releasing the 









Appendix D – Verbal Consent Form 
Hello! My name is Tierney Boyce and I am a student in the Master of Science in Public Health 
and Health Systems program at the University of Waterloo. For my thesis research, I am 
conducting semi-structured, in-depth interviews with women in larger bodies who have accessed 
and used female methods of birth control or emergency contraception in Ontario in the last five 
years. I will be asking you to share your experiences with contraception and contraceptive care, 
and your feelings during and about these experiences. 
You were identified through [insert wording such as name of: social media website; website; 
suggestion by previous participant/mutual contact].  
What will happen during this study? 
I am inviting you to do a one-on-one interview [through an online platform of the participant’s 
choice, such as Skype, WhatsApp, Microsoft Teams, or over the phone] that will take about one 
hour. The interview will begin by asking you a broad question to introduce yourself. I will then 
ask some brief demographic questions, including your age, ethnicity, whether you live in a rural 
or urban setting, your level of education, and your sexual orientation. Throughout the rest of the 
interview, I will ask you questions about your experiences accessing and using female 
contraception, and your feelings about these experiences, such as “Could you describe your 
experiences with contraception?”, “Can you walk me through your experiences of receiving 
contraceptive counselling and the process of accessing contraception?”, and “Could you describe 
what contraception means to you?”. With your permission, I will take brief hand-written notes 
and I will use audio recorder to make sure to capture everything you say. We will set up a time 
and place that works best for you.  
Are there any risks to participating in this study? 
The risks involved in participating in this study are minimal. You should be aware that some 
participants may feel uncomfortable discussing their private sexual and reproductive health 
experiences. During the interview, you may decline to answer any of the interview questions 
and/or share your personal information with me. If you ever feel distressed, please let me know 
and we can pause or end the interview. I am trained on how to navigate these situations and will 
provide you with support resources that can be shared with you if you are interested. Finally, you 
may withdraw from this study at any time. If you decide to withdraw, I can also erase the 
interview transcript and any notes that I may have taken during the interview process.  
Your identity will remain confidential. Your name or any other personally identifying 
information will not appear in my thesis, any presentations, or publications resulting from this 
study. To protect your identity, you will be assigned a pseudonym, which you may choose, and I 
will erase the audio-recording of your interview right after I transcribe it. The transcription will 







Are there any benefits to participating in this study? 
It is unlikely that there will be direct benefits to you; however, I hope that the data collected from 
these interviews will help us to understand women in larger bodies’ experiences with 
contraception in Ontario, and may be used to inform future research. The knowledge gained from 
this study may one day be used to contribute to the development of clinical practice guidelines, 
policy, or make recommendations on how to improve contraceptive care in Ontario. 
Voluntary participation 
➢ Your participation in this study is completely voluntary.  
➢ You can decide to stop at any time, even part-way through the interview for whatever 
reason. 
➢ If you decide to stop participating, there will be no consequences to you.   
➢ If you decide to stop, we will ask you how you would like us to handle the data collected 
up to that point.   
➢ This could include returning it to you, destroying it or using the data collected up to that 
point.   
➢ If you do not want to answer some of the questions you do not have to, but you can still 
be in the study. 
➢ If you have any questions about this study or would like more information, please refer to 
the full information letter, you may e-mail me at tierney.boyce@uwaterloo.ca  or you can 
call or email Dr. Elena Neiterman at (519) 888-4567 ext. 38221 or 
eneiterman@uwaterloo.ca  
 
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee (ORE# 42481). If you have questions for the Committee, contact the 
Office of Research Ethics, at 1-519-888-4567 ext. 36005 or ore-ceo@uwaterloo.ca. 
 
Consent questions: 
• Do you have any questions or would like any additional details? [Answer questions.] 
• Do you agree to participate in this study knowing that you can withdraw at any point with 
no consequences to you? [If yes, move to next question/ If no, thank the participant for 
her time.]  
• Do you consent to having your interview audio recorded? 
• Do you agree to the use of anonymous quotations for future research or publications 
developed from this thesis? 
• Do you give me, Tierney Boyce, permission to retain a copy of the interview transcript 
for a minimum period of seven years and use it for research purposes as long as it has no 







Appendix E – Interview Guide 
1. How would you describe yourself to someone who has never met you before? 
➢ Demographic Questionnaire:  
▪ What is your age?                      _______________ 
▪ What is your ethnicity?                     _______________ 
▪ Do you live in an urban or rural location?                       _______________ 
▪ What is your level of education?          _______________ 
▪ What is your sexual orientation?         _______________ 
 
2. Could you describe your experiences with contraception? 
➢ What are your preferred methods? Why? 
➢ How does your body respond to contraception? 
 
3. Can you walk me through your experiences of receiving contraceptive counselling (if you 
have received it) and the process of accessing contraception? 
➢ Could you describe your interactions with health care providers? 
➢ How did you feel during the counselling [or when accessing contraception] (i.e., 
interactions with health care providers)? 
➢ What did you think about the counselling that you received (i.e., quality, options 
presented) [or care received when accessing contraception]? 
 
4. How confident are you about preventing pregnancy when you use contraception (if 
applicable)?  
➢ Has there ever been a time where you felt your contraception may have failed?  
➢ What signals (if any) did your body give you? What did you do? 
➢ Have you ever considered using emergency contraception? If so, could you tell me about 
how you felt about emergency contraception? (e.g., attitudes, knowledge) 
 
5. If applicable: Can you tell me about a situation where you used emergency contraception? 
➢ Could you describe the timeline between sex and using emergency contraception? 
➢ How did you decide which method of emergency contraception to use? 
➢ Could you describe how you (and your body) felt throughout this process? 
 
6. In your own words, could you describe what contraception means to you?  







7. Overall, what have you found to be helpful when accessing and using contraception? What 
have you found unhelpful?  
➢ What can you tell me about the information, counselling, or care you received? 
➢ What did you value about the care you received? 
➢ What, if anything, would you change or improve? 
 
8. Reflecting on this experience and other experiences with health care services, how would you 
compare contraceptive care?  
➢ Was it easier or more challenging? How so? 
➢ Did you feel well-supported? 
 
















Appendix F – Feedback Letter 
Exploring the lived experiences of women in larger bodies who access and use 
contraception in Ontario 
[date] 
Dear [name], 
I would like to thank you for your participation in this study entitled Exploring the lived 
experiences of women in larger bodies who access and use contraception in Ontario. As a 
reminder, the purpose of this study was to learn about women’s experiences and suggest how 
contraceptive care can be improved for women in larger bodies. 
The data collection from your interview will contribute to a better understanding of the 
experiences of women in larger bodies who access and use routine female contraception or 
emergency contraception, how contraceptive care is navigated and experienced, and how women 
in larger bodies feel during and about these experiences. 
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee (ORE #42481). If you have any questions for the Committee, please 
contact the Office of Research Ethics at (519) 888-4567 ext. 36005 or ore-ceo@uwaterloo.ca. 
For all other questions, please contact, Tierney Boyce (tierney.boyce@uwaterloo.ca) or Dr. 
Elena Neiterman (eneiterman@uwaterloo.ca). 
Please remember that any data pertaining to you as an individual participant will be kept 
confidential. The findings from this study may be shared through conferences, presentations, and 
journal articles. However, the experiences you share will not be attributed to you and your 
identity will not be revealed. If you would like to receive the report from this study, please 




University of Waterloo 









Appendix G – Participant Resources 
Sexual health services and information (birth control, sexually transmitted 
infection testing)  
Sexual Health Infoline Ontario (SHILO) – anonymous toll-free 1-800-668-2437 
OR e-chat https://www.toronto.ca/community-people/health-wellness-care/sexual-
health-infoline-ontario/ 
Sexual Health Ontario – https://www.sexualhealthontario.ca/  
Action Canada for Sexual Health & Rights – https://www.actioncanadashr.org/  
Sex & U – https://www.sexandu.ca/   
It’s a plan – https://www.itsaplan.ca/  
 
 
Mental Health Support 
Mental Health Helpline – 1-866-531-2600  
ConnexOntario – 1-866-531-2600 OR https://www.connexontario.ca/  
 
 
Health advice and information 
Telehealth Ontario – 1-866-797-0000  
 
*If you are in a mental health crisis, call Telehealth Ontario 









Appendix H – Participant History of Female-Oriented Contraceptive Use  
Pseudonym Routine contraception Emergency contraception 
Alice 
 








































Quinn OCPs, Vaginal ring,  
Cu-IUD, Tubal ligation* 




OCPs, Contraceptive injection, 
Vaginal ring, LNG-IUD 
 

















*Methods that were not specified in the inclusion criteria or recruitment materials but were 
incidentally discussed in the interviews.  
